Search for: "Aventis"
Genzyme Confirms Receipt of Unsolicited Proposal
HSMN NewsFeed,
30 Aug 2010:
Biopharmaceuticals, Mergers & Acquisitions[Genzyme, Sanofi-Aventis]
Teriflunomide Significantly Reduced Annualized Relapse Rate and was Well Tolerated in MS Patients
HSMN NewsFeed,
30 Aug 2010:
Biopharmaceuticals, Neurology[Sanofi-aventis, multiple sclerosis, teriflunomide, TEMSO trial]
sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme
HSMN NewsFeed,
29 Aug 2010:
Biopharmaceuticals, Mergers & Acquisitions[sanofi-aventis, Genzyme]
ImmunoGen, Inc. Announces Orphan Drug Designation Granted to Lorvotuzumab Mertansine for Treatment of Small-Cell Lung Cancer
HSMN NewsFeed,
18 Aug 2010:
Biopharmaceuticals, Oncology, FDA[ImmunoGen, lorvotuzumab mertansine, lung cancer]
Data from First Phase 3 Trial (EDEMA3(R)) for KALBITOR(R) (ecallantide) Published in The New England Journal of Medicine
HSMN NewsFeed,
5 Aug 2010:
Biopharmaceuticals[Dyax, EDEMA3, KALBITOR, ecallantide, hereditary angioedema]
Exelixis Regains Full Rights to Develop and Commercialize XL184
HSMN NewsFeed,
21 Jun 2010:
Biopharmaceuticals[Exelixis, Bristol-Myers Squibb, XL184, MET inhibitor]
aTyr Pharma Appoints Catharine E. Johnson As Senior Vice President of Business Development
HSMN NewsFeed,
14 Jun 2010:
Biopharmaceuticals, Personnel[aTyr Pharma]
KV Pharmaceutical Company Announces New Board Members and Restructuring of Senior Executive Management
HSMN NewsFeed,
11 Jun 2010:
Biopharmaceuticals, Personnel[KV Pharmaceutical]
APP Pharmaceuticals to Market Oxaliplatin Injection (Liquid) in the U.S.
HSMN NewsFeed,
11 Jun 2010:
Biopharmaceuticals, Oncology[APP Pharmaceuticals, Fresenius Kabi, Oxaliplatin, Eloxatin, sanofi-aventis]
Teriflunomide in Adjunct to Interferon Beta Significantly Improved Outcomes of Multiple Sclerosis Patients
HSMN NewsFeed,
7 Jun 2010:
Biopharmaceuticals, Neurology[Sanofi-aventis, teriflunomide, multiple sclerosis]
Teva Announces Positive Results from a Study Assessing a New Formulation of Copaxone(R)
HSMN NewsFeed,
4 Jun 2010:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, Copaxone, glatiramer, Multiple Sclerosis]
Ascenta Therapeutics Licenses Cancer Drug Candidates to sanofi-aventis
HSMN NewsFeed,
4 Jun 2010:
Biopharmaceuticals, Oncology, Licensing[Ascenta Therapeutics, sanofi-aventis, HDM2, p53]
Ikaria(R) Names New Head of Research & Development
HSMN NewsFeed,
1 Jun 2010:
Biopharmaceuticals, Personnel[Ikaria, INOMAX, nitric oxide]
Tesaro, Inc. Secures $60 Million in Start-up Funding
HSMN NewsFeed,
26 May 2010:
Biopharmaceuticals, Oncology, Venture Capital, Personnel[TESARO]
Cleveland BioLabs Adds Regulatory Affairs Expertise to Development Team
HSMN NewsFeed,
24 May 2010:
Biopharmaceuticals, Personnel[Cleveland BioLabs]
Cempra Announces Expansion of Clinical Management Team to Advance Leading Antibacterial Clinical Programs TAKSTA(TM) and CEM-101
HSMN NewsFeed,
6 Apr 2010:
Biopharmaceuticals, Personnel[Cempra Pharmaceuticals, antibiotic]
Par Pharmaceutical Enters Into Agreement With sanofi-aventis to Settle Patent Litigation Over Generic Eloxatin(R)
HSMN NewsFeed,
5 Apr 2010:
Biopharmaceuticals, Generics, Oncology, Litigation[Par Pharmaceutical, sanofi-aventis, Debiopharm, Eloxatin, oxaliplatin]
Teva Settles Generic Eloxatin Litigation
HSMN NewsFeed,
1 Apr 2010:
Biopharmaceuticals, Generics, Litigation[Teva Pharmaceutical, sanofi-aventis, Debiopharm, oxaliplatin, Eloxatin]
Biodel Announces Senior Leadership Changes
HSMN NewsFeed,
30 Mar 2010:
Biopharmaceuticals, Personnel[Biodel]
Inadequate Response to Clopidogrel Leads to Higher Incidence of Major Adverse Cardiac Events in Patients Who have Undergone PCI
HSMN NewsFeed,
15 Mar 2010:
Biopharmaceuticals, Diagnostics, Cardiology[Accumetrics, VerifyNow, antiplatelet agents, clopidogrel]
Endo Pharmaceuticals Announces Appointment of New Chief Operating Officer
HSMN NewsFeed,
12 Mar 2010:
Biopharmaceuticals, Personnel[Endo Pharmaceuticals]
sanofi-aventis Successfully Completes the Acquisition of Chattem, Inc.
HSMN NewsFeed,
11 Mar 2010:
Biopharmaceuticals, Mergers & Acquisitions[sanofi-aventis, Chattem, Allegra, fexofenadine]
SurModics Announces Organizational and Leadership Changes
HSMN NewsFeed,
4 Mar 2010:
Devices, Personnel[SurModics]
Sanofi-Aventis and Novalar Enter Exclusive License Agreement to Commercialize OraVerse(R) in Germany
HSMN NewsFeed,
3 Mar 2010:
Biopharmaceuticals, Licensing[Novalar Pharmaceuticals, Sanofi-Aventis Deutschland, OraVerse]
Copaxone(R) 15-Year Study in Multiple Sclerosis Patients Demonstrates Robust Long-Term Efficacy and Safety
HSMN NewsFeed,
25 Feb 2010:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, Copaxone, glatiramer, multiple sclerosis]
Study Showed Sculptra(R) Aesthetic Effectively Corrects Nasolabial Folds and Other Facial Wrinkles
HSMN NewsFeed,
23 Feb 2010:
Biopharmaceuticals, Dermatology[sanofi-aventis, Sculptra, nasolabial fold, CosmoPlast]
Lantheus Medical Imaging, Inc. Announces Appointment of Robert A. Spurr as Vice President, Sales and Marketing
HSMN NewsFeed,
17 Feb 2010:
Biopharmaceuticals, Radiology, Personnel[Lantheus Medical Imaging]
Abraxis BioScience Confirms Plan to Spin-off Abraxis Health in 2010 and Announces Management Structure
HSMN NewsFeed,
28 Jan 2010:
Biopharmaceuticals, Personnel[Abraxis BioScience, Abraxis Health]
Spectrum Pharmaceuticals Announces Results of FDA Meeting Regarding FUSILEV(R) sNDA under Review for Advanced Metastatic Colorectal Cancer
HSMN NewsFeed,
25 Jan 2010:
Biopharmaceuticals, Oncology, FDA[Spectrum Pharmaceuticals, FUSILEV, levoleucovorin, colorectal cancer]
Industry Veteran Ron Branning Joins Genzyme to Lead Global Product Quality
HSMN NewsFeed,
8 Jan 2010:
Biopharmaceuticals, Personnel[Genzyme]
New Analysis Showed Effient(R) Cost-Effective Compared with Clopidogrel for Patients with Acute Coronary Syndromes Undergoing PCI
HSMN NewsFeed,
5 Jan 2010:
Biopharmaceuticals, Interventional Cardiology[Eli Lilly, Effient, prasugrel, sanofi-aventis, Plavix, clopidogrel]
Aeterna Zentaris Announces Termination of Agreement with sanofi-aventis U.S. for the Development, Commercialization and Licensing of Cetrorelix in Benign Prostatic Hyperplasia
HSMN NewsFeed,
18 Dec 2009:
Biopharmaceuticals, Urology[AETERNA ZENTARIS, sanofi-aventis, cetrorelix, benign prostatic hyperplasia]
ImmunoGen, Inc. Appoints Suzanne Cadden as Vice President, Regulatory Affairs & Quality
HSMN NewsFeed,
17 Dec 2009:
Biopharmaceuticals, Oncology, Personnel[ImmunoGen]
Access Pharmaceuticals Appoints Sales and Marketing Executive
HSMN NewsFeed,
15 Dec 2009:
Biopharmaceuticals, Oncology, Personnel[Access Pharmaceuticals, MuGard, oral mucositis]
Former Wyeth Executive Joins VaxInnate as Chief Operating Officer
HSMN NewsFeed,
9 Dec 2009:
Biopharmaceuticals, Personnel[VaxInnate, vaccine]
Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer
HSMN NewsFeed,
4 Dec 2009:
Devices, Dermatology, Personnel[Suneva Medical, Artefill, collagen]
Dyax Announces FDA Approval of KALBITOR(R) (ecallantide) for the Treatment of Acute Attacks of Hereditary Angioedema in Patients 16 Years of Age and Older
HSMN NewsFeed,
1 Dec 2009:
Biopharmaceuticals, FDA[Dyax, KALBITOR, ecallantide, hereditary angioedema]
sanofi-aventis U.S. and Intelliject, Inc. Sign Licensing Agreement for Novel Epinephrine Auto Injector in North America
HSMN NewsFeed,
30 Nov 2009:
Devices, Biopharmaceuticals, Drug Delivery, Licensing[sanofi-aventis, Intelliject, epinephrine, injector]
sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation
HSMN NewsFeed,
30 Nov 2009:
Biopharmaceuticals, Cardiology, Regulatory[sanofi-aventis, Multaq, dronedarone, atrial fibrillation]
XOMA Appoints Jim Neal Vice President of Business Development
HSMN NewsFeed,
17 Nov 2009:
Biopharmaceuticals, Personnel[XOMA]
NeurogesX Expands Commercial Operations Leadership Team
HSMN NewsFeed,
5 Nov 2009:
Biopharmaceuticals, Personnel[NeurogesX, Qutenza, capsaicin]
Delcath Systems Completes Executive Management Team with Strategic New Hires
HSMN NewsFeed,
23 Oct 2009:
Devices, Personnel[Delcath Systems]
Wellstat Therapeutics and sanofi-aventis Enter Agreement on Novel Therapy for Type II Diabetes
HSMN NewsFeed,
21 Oct 2009:
Biopharmaceuticals, Endocrinology[Wellstat Therapeutics, sanofi-aventis, insulin resistance]
FDA Approves Elitek(R) (rasburicase) for Management of Plasma Uric Acid Levels in Adults with Leukemia, Lymphoma, and Solid Tumors Receiving Anti-Cancer Therapy
HSMN NewsFeed,
16 Oct 2009:
Biopharmaceuticals, FDA[sanofi-aventis, Elitek, rasburicase]
Seattle Genetics Names Head of Commercial and Announces Management Promotion
HSMN NewsFeed,
13 Oct 2009:
Biopharmaceuticals, Personnel[Seattle Genetics]
sanofi-aventis: Multaq(R) (dronedarone) Recommended for Approval in the European Union
HSMN NewsFeed,
28 Sep 2009:
Biopharmaceuticals, Cardiology, Regulatory[sanofi-aventis, Multaq, dronedarone, atrial fibrillation]
Johnson & Johnson and Crucell Announce Strategic Collaboration to Develop Innovative Products, Including Therapies for Influenza Prevention and Treatment
HSMN NewsFeed,
28 Sep 2009:
Biopharmaceuticals[Johnson & Johnson, Crucell, Ortho-McNeil-Janssen]
sanofi-aventis Completes Acquisition of Merck's Interest in Merial
HSMN NewsFeed,
18 Sep 2009:
Biopharmaceuticals, Mergers & Acquisitions[Merck, sanofi-aventis, Merial]
COPAXONE(R) Significantly Reduced Disease Severity in Long-Term Treated Multiple Sclerosis Patients
HSMN NewsFeed,
10 Sep 2009:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, COPAXONE, glatiramer, multiple sclerosis]
sanofi-aventis: Study Shows Otamixaban Substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes
HSMN NewsFeed,
31 Aug 2009:
Biopharmaceuticals, Cardiology[sanofi-aventis, otamixaban, SEPIA-ACS1, TIMI-42, Acute Coronary Syndromes]
New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of Plavix(R) in Acute Coronary Syndrome Patients Undergoing Angioplasty
HSMN NewsFeed,
30 Aug 2009:
Biopharmaceuticals, Interventional Cardiology[Bristol-Myers Squibb, sanofi-aventis, Plavix, clopidogrel]
Mylan Begins Marketing First Generic Version of BenzaClin(R) Acne Treatment
HSMN NewsFeed,
27 Aug 2009:
Biopharmaceuticals, Generics, Dermatology[Mylan, Clindamycin, Benzoyl Peroxide, BenzaClin, sanofi-aventis, acne]
FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria
HSMN NewsFeed,
24 Aug 2009:
Biopharmaceuticals, FDA[UCB, sanofi-aventis, XYZAL, levocetirizine dihydrochloride]
Real-World Study Showed Cost Savings for VTE Prophylaxis with Enoxaparin Compared with Unfractionated Heparin (UFH)
HSMN NewsFeed,
17 Aug 2009:
Biopharmaceuticals[sanofi-aventis, Lovenox, enoxaparin, heparin, venous thromboembolism]
AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia
HSMN NewsFeed,
17 Aug 2009:
Biopharmaceuticals, Urology[AETERNA ZENTARIS, Z-033, Z-041, cetrorelix, benign prostatic hyperplasia]
Teva Announces Approval and Launch of Oxaliplatin Injection
HSMN NewsFeed,
11 Aug 2009:
Biopharmaceuticals, Generics, Oncology, FDA[Teva Pharmaceutical, oxaliplatin, Eloxatin, sanofi-aventis, colorectal cancer]
Hospira Launches Generic Oxaliplatin Injection
HSMN NewsFeed,
11 Aug 2009:
Biopharmaceuticals, Generics, Oncology, FDA[Hospira, oxaliplatin, Eloxatin, sanofi-aventis, colorectal cancer]
Perrigo Announces FDA Approval for Generic Version of NASACORT(R) AQ
HSMN NewsFeed,
3 Aug 2009:
Biopharmaceuticals, Generics, FDA[Perrigo, Teva Pharmaceutical, triamcinolone acetonide, NASACORT]
FDA Approves Sculptra(R)Aesthetic, a Facial Injectable for Correction of Nasolabial Folds and Other Facial Wrinkles
HSMN NewsFeed,
29 Jul 2009:
Biopharmaceuticals, Dermatology, FDA[sanofi-aventis, SculptraAesthetic, poly-L-lactic acid, nasolabial fold]
Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America
HSMN NewsFeed,
29 Jul 2009:
Biopharmaceuticals, Oncology[Access Pharmaceuticals, MuGard, oral mucositis]
Watson Announces License Agreement With GeneraMedix for Generic Version of Ferrlecit(R)
HSMN NewsFeed,
28 Jul 2009:
Biopharmaceuticals, Generics, Licensing[Watson Pharmaceuticals, GeneraMedix, sanofi-aventis, Ferrlecit]
MULTAQ(R) (dronedarone) for Atrial Fibrillation or Atrial Flutter Now Available in the United States
HSMN NewsFeed,
28 Jul 2009:
Biopharmaceuticals, Cardiology[sanofi-aventis, MULTAQ, dronedarone, atrial fibrillation, atrial flutter]
Regeneron Receives European Medicines Agency Positive Opinion for Marketing Authorization of Rilonacept for the Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)
HSMN NewsFeed,
24 Jul 2009:
Biopharmaceuticals, Regulatory[Regeneron Pharmaceuticals, rilonacept, Cryopyrin-Associated Periodic Syndromes]
Dicerna Pharmaceuticals Announces Appointment of Industry Veteran David Madden as Chairman of the Board
HSMN NewsFeed,
8 Jul 2009:
Biopharmaceuticals, Personnel[Dicerna Pharmaceuticals]
OncoMed Pharmaceuticals Appoints Sunil Patel Senior Vice President, Corporate Development
HSMN NewsFeed,
7 Jul 2009:
Biopharmaceuticals, Personnel[OncoMed Pharmaceuticals]
FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter
HSMN NewsFeed,
2 Jul 2009:
Biopharmaceuticals, Cardiology, FDA[sanofi-aventis, Multaq, dronedarone, atrial fibrillation, atrial flutter]
Hospira Receives Favorable Court Decision on Eloxatin(R)
HSMN NewsFeed,
18 Jun 2009:
Biopharmaceuticals, Generics, FDA[Hospira, Sanofi Aventis, Eloxatin, oxaliplatin]
Echo Therapeutics and Handok Pharmaceuticals Sign South Korea License for Needle-free Symphony(TM) Transdermal Continuous Glucose Monitoring System
HSMN NewsFeed,
17 Jun 2009:
Devices, Monitoring, Licensing, Endocrinology[Echo Therapeutics, Handok Pharmaceuticals, Symphony tCGM System]
Novo Nordisk: New study directly comparing insulin delivery devices shows that Next Generation FlexPen has a significantly lower injection force than SoloStar and KwikPen
HSMN NewsFeed,
29 May 2009:
Biopharmaceuticals, Drug Delivery, Endocrinology[Novo Nordisk, FlexPen, insulin delivery]
Accumetrics, Inc. Announces European Distribution Channels for France, Austria, Switzerland, Netherlands, Belgium and Luxembourg
HSMN NewsFeed,
27 May 2009:
Diagnostics, Cardiology, Distribution[Accumetrics, VerifyNow, GP IIb/IIIa, antiplatelet]
New Jersey Doctors Now Delivering Non-Invasive, Image-Guided Radiosurgery Treatments Using Novalis Tx(TM) Technology
HSMN NewsFeed,
27 May 2009:
Devices, Oncology[Varian Medical Systems, Novalis Tx, BrainLAB, radiosurgery]
Marty J. Duvall Joins Abraxis BioScience as Senior Vice President, Global Marketing and International Commercial Operations
HSMN NewsFeed,
22 May 2009:
Biopharmaceuticals, Personnel[Abraxis BioScience]
Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial
HSMN NewsFeed,
21 May 2009:
Biopharmaceuticals, Cardiology[Eli Lilly, prasugrel, clopidogrel, acute coronary syndromes]
InVasc Therapeutics Announces Executive and Board Appointments
HSMN NewsFeed,
15 May 2009:
Biopharmaceuticals, Personnel[InVasc Therapeutics]
Follica Appoints Drug Development and Dermatology Veteran, William D. Ju, as Chief Executive Officer
HSMN NewsFeed,
13 May 2009:
Biopharmaceuticals, Personnel[Follica]
Sanofi-aventis U.S. to Acquire Oral Chronic Lymphocytic Leukemia Treatment
HSMN NewsFeed,
11 May 2009:
Biopharmaceuticals, Oncology, Acquisitions[sanofi-aventis, Antisoma, Oforta, fludarabine, B-cell CLL]
Abraxis BioScience Names Lonnie Moulder President and Chief Executive Officer; Soon-Shiong Remains Executive Chairman
HSMN NewsFeed,
30 Apr 2009:
Biopharmaceuticals, Personnel[Abraxis BioScience]
Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
HSMN NewsFeed,
30 Apr 2009:
Biopharmaceuticals, Ophthalmology[Regeneron Pharmaceuticals, Bayer HealthCare, VEGF Trap-Eye, CRVO]
Long-Term Study with COPAXONE Indicated Protective Effect on Brain Tissue in Multiple Sclerosis Patients
HSMN NewsFeed,
28 Apr 2009:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, COPAXONE, glatiramer, multiple sclerosis]
Apidra(R) SoloSTAR(R), the Easy-to-Use Insulin Delivery Device from sanofi-aventis, Now Available in the United States
HSMN NewsFeed,
20 Apr 2009:
Devices, Biopharmaceuticals, Drug Delivery, Endocrinology[sanofi-aventis, Apidra , SoloSTAR, insulin glulisine, diabetes]
Pfizer's Oncology Business Unit Appoints Vice President of Medical Affairs
HSMN NewsFeed,
10 Apr 2009:
Biopharmaceuticals, Oncology, Personnel[Pfizer]
World-First Launch of New Heart Drug
HSMN NewsFeed,
8 Apr 2009:
Biopharmaceuticals, Interventional Cardiology[DAIICHI SANKYO, Eli Lilly, prasugrel, Efient, Acute Coronary Syndromes]
Aplenzin(TM), the Only Single Tablet Once-Daily Treatment for Depression at All Doses, Now Available in the United States
HSMN NewsFeed,
7 Apr 2009:
Biopharmaceuticals[sanofi-aventis, Aplenzin, bupropion, depressive disorder]
Perrigo Announces FDA Approval for Sulfacetamide Sodium Topical Suspension USP, 10% (Lotion)
HSMN NewsFeed,
24 Mar 2009:
Biopharmaceuticals, Generics, FDA[Perrigo, Sulfacetamide, Sanofi-Aventis, Klaron, acne]
FDA Advisory Committee Recommends Approval of Multaq(R) (dronedarone)
HSMN NewsFeed,
18 Mar 2009:
Biopharmaceuticals, Cardiology, FDA[sanofi-aventis, Multaq, dronedarone, atrial fibrillation]
Paul Chew Appointed to sanofi-aventis U.S. Chief Science Officer/Chief Medical Officer
HSMN NewsFeed,
16 Mar 2009:
Biopharmaceuticals, Personnel[sanofi-aventis]
Sanofi-aventis and AEterna Zentaris Sign Agreement in the U.S.
HSMN NewsFeed,
6 Mar 2009:
Biopharmaceuticals, Licensing, Urology[sanofi-aventis, AEterna Zentaris, cetrorelix, benign prostatic hyperplasia]
AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia
HSMN NewsFeed,
6 Mar 2009:
Biopharmaceuticals, Licensing, Urology[AETERNA ZENTARIS, sanofi-aventis, cetrorelix, benign prostatic hyperplasia]
Gregory J. Tibbitts Appointed Chief Financial Officer at Accumetrics, Inc.
HSMN NewsFeed,
26 Feb 2009:
Devices, Diagnostics, Personnel[Accumetrics, VerifyNow, antiplatelet]
FDA Approves Apidra(R) SoloSTAR(R) - a Prefilled Disposable Insulin Pen
HSMN NewsFeed,
26 Feb 2009:
Biopharmaceuticals, Drug Delivery, Endocrinology, FDA[sanofi-aventis, Apidra, SoloSTAR, Lantus]
European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI
HSMN NewsFeed,
23 Feb 2009:
Biopharmaceuticals, Cardiology, Regulatory[Eli Lilly, Daiichi Sankyo, acute coronary syndrome, EFIENT , prasugrel]
New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation
HSMN NewsFeed,
11 Feb 2009:
Biopharmaceuticals, Cardiology[sanofi-aventis, ATHENA trial, Multaq, dronedarone, atrial fibrillation]
Jean-Pierre Lehner Appointed Chief Medical Officer
HSMN NewsFeed,
11 Feb 2009:
Biopharmaceuticals, Personnel[sanofi-aventis]
Laurence Debroux Appointed Chief Strategic Officer (CSO)
HSMN NewsFeed,
11 Feb 2009:
Biopharmaceuticals, Personnel[sanofi-aventis]
COPAXONE(R) is Approved for Treatment of Patients with a First Clinical Event Suggestive of Multiple Sclerosis
HSMN NewsFeed,
4 Feb 2009:
Biopharmaceuticals, Neurology, Regulatory[Teva Pharmaceutical, COPAXONE, glatiramer, multiple sclerosis]
Prasugrel Receives Unanimous Approval Recommendation from FDA Advisory Committee
HSMN NewsFeed,
3 Feb 2009:
Biopharmaceuticals, Cardiology, FDA[Eli Lilly, prasugrel, antiplatelet, acute coronary syndrome]
Dr. Steven L. Zelenkofske Joins Regado Biosciences as Senior Vice President, Clinical and Medical Affairs and Chief Medical Officer
HSMN NewsFeed,
15 Jan 2009:
Biopharmaceuticals, Personnel[Regado Biosciences, aptamer therapeutic, aptamer]
ARIAD Expands Management Team with Executive Appointments in Regulatory Affairs, Manufacturing and Information Technology
HSMN NewsFeed,
6 Jan 2009:
Biopharmaceuticals, Personnel[ARIAD Pharmaceuticals]
Prism Pharmaceuticals Receives FDA Approval of NEXTERONE(R) for Life-Threatening Ventricular Fibrillation and Ventricular Tachycardia
HSMN NewsFeed,
5 Jan 2009:
Biopharmaceuticals, Cardiology[Prism Pharmaceuticals, NEXTERONE, amiodarone, Wyeth, Cordarone]
Biovail Enters into Commercial Alliance for Aplenzin
HSMN NewsFeed,
22 Dec 2008:
Biopharmaceuticals, Distribution[Biovail, sanofi-aventis, Aplenzin, bupropion]
Cubist Names Santosh J. Vetticaden as SVP, Clinical Development and Chief Medical Officer
HSMN NewsFeed,
2 Dec 2008:
Biopharmaceuticals, Personnel[Cubist Pharmaceuticals]
Helsinn Healthcare and Zealand Pharma Sign a Partnering Agreement for ZP1846, a Novel GLP-2 Agonist
HSMN NewsFeed,
27 Nov 2008:
Biopharmaceuticals, Oncology[Helsinn Healthcare, Zealand Pharma, ZP1846, chemotherapy-induced diarrhea]
Accumetrics, Inc. Appoints William Dippel as Executive Vice President of Operations and R&D
HSMN NewsFeed,
4 Nov 2008:
Diagnostics, Cardiology, Personnel[Accumetrics, VerifyNow, antiplatelet, Plavix, ReoPro, Integrilin]
Timothy I. Still Appointed CEO at Accumetrics
HSMN NewsFeed,
30 Oct 2008:
Diagnostics, Personnel[Accumetrics]
FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes
HSMN NewsFeed,
29 Oct 2008:
Biopharmaceuticals, FDA, Endocrinology[Sanofi-aventis, Apidra, insulin glulisine, diabetes]
CoLucid Pharmaceuticals Names Linda Hogan VP of Business Development
HSMN NewsFeed,
28 Oct 2008:
Biopharmaceuticals, Personnel[CoLucid Pharmaceuticals]
Mylan Receives Tentative FDA Approval for First-to-File Generic Version of Blood Pressure Drug Benicar HCT(R)
HSMN NewsFeed,
22 Oct 2008:
Biopharmaceuticals, Generics, FDA[Mylan, Mylan Pharmaceuticals, Olmesartan Medoxomil, Daiichi Sankyo, Benicar HCT]
Micronics Completes Series C Financing
HSMN NewsFeed,
16 Oct 2008:
Diagnostics, Venture Capital[Micronics]
Cordis Announces New Leadership Positions in Key Business Groups
HSMN NewsFeed,
13 Oct 2008:
Devices, Cardiology, Personnel[Cordis, Johnson & Johnson]
MiddleBrook Pharmaceuticals Announces Changes to Management Team
HSMN NewsFeed,
7 Oct 2008:
Biopharmaceuticals, Personnel[MiddleBrook Pharmaceuticals]
Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
HSMN NewsFeed,
1 Oct 2008:
Biopharmaceuticals, Drug Delivery, FDA[Transcept Pharmaceuticals, Intermezzo, zolpidem, Bimucoral, insomnia]
Alnylam Appoints Industry Leader John Schmidt as Chief Scientific Officer
HSMN NewsFeed,
1 Oct 2008:
Biopharmaceuticals, Personnel[Alnylam Pharmaceuticals]
FDA Approves Nasacort AQ(R) Nasal Spray for Children Aged 2-5 years old
HSMN NewsFeed,
23 Sep 2008:
Biopharmaceuticals, FDA[sanofi-aventis, Nasacort AQ, triamcinolone, rhinitis]
Longest Prospective Study in MS Confirmed Robust Clinical Benefits and Safety of COPAXONE(R)
HSMN NewsFeed,
18 Sep 2008:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, multiple sclerosis, COPAXONE, glatiramer]
Cambridge Laboratories Announces New Marketing Arrangements for XENAZINE(R) in North America
HSMN NewsFeed,
17 Sep 2008:
Biopharmaceuticals, Neurology[Cambridge Laboratories, XENAZINE, tetrabenazine, Huntington's disease]
AmpliMed Announces License Agreement with Handok Pharmaceuticals for Exclusive Rights to Cancer Therapeutic Amplimexon(R) in Korea
HSMN NewsFeed,
10 Sep 2008:
Biopharmaceuticals, Licensing[AmpliMed, Handok Pharmaceuticals, Amplimexon, imexon]
Zosano Pharma, Inc. Announces Appointment of Gail Schulze as Chair and CEO
HSMN NewsFeed,
8 Sep 2008:
Biopharmaceuticals, Personnel[Zosano Pharma]
Clinical Data Indicate that Percutaneous Coronary Intervention with the CYPHER(R) Sirolimus-eluting Coronary Stent Is Comparable to Bypass Surgery in Key Safety Measures in Patients with Diabetes and Multi-Vessel Disease
HSMN NewsFeed,
4 Sep 2008:
Devices, Interventional Cardiology[Cordis, Johnson & Johnson, CYPHER, drug eluting stent]
Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing
HSMN NewsFeed,
3 Sep 2008:
Biopharmaceuticals, Venture Capital[Osprey Pharmaceuticals]
Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel
HSMN NewsFeed,
3 Sep 2008:
Biopharmaceuticals, Cardiology[Eli Lilly, TRITON-TIMI 38, prasugrel, clopidogrel, acute coronary syndromes]
Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation
HSMN NewsFeed,
3 Sep 2008:
Biopharmaceuticals, Cardiology[Sanofi-aventis, Multaq, Dronedarone, stroke, Atrial Fibrillation, ATHENA study]
BioAlliance Pharma SA appoints Pierre MORGON Chief Operating Officer
HSMN NewsFeed,
27 Aug 2008:
Biopharmaceuticals, Personnel[BioAlliance Pharma]
QLT announces agreement to exclusively license the Atrigel(R) Technology to Reckitt Benckiser Pharmaceuticals Inc.
HSMN NewsFeed,
26 Aug 2008:
Biopharmaceuticals, Drug Delivery, Licensing[QLT, QLT USA, Reckitt Benckiser Pharmaceuticals, Atrigel]
Regeneron and Bayer HealthCare Announce VEGF Trap-Eye Achieved Durable Improvement in Vision over 52 Weeks in a Phase 2 Study in Patients with Age-Related Macular Degeneration
HSMN NewsFeed,
19 Aug 2008:
Biopharmaceuticals, Opthalmology[Regeneron Pharmaceuticals, Bayer HealthCare AG, macular degeneration, VEGF Trap]
Onyx Pharmaceuticals Names Juergen Lasowski, Ph.D. as Senior Vice President of Corporate Development
HSMN NewsFeed,
15 Aug 2008:
Biopharmaceuticals, Personnel[Onyx Pharmaceuticals]
ImmunoGen, Inc. Announces sanofi-aventis Licenses Expanded Access to the Company's TAP Technology
HSMN NewsFeed,
12 Aug 2008:
Biopharmaceuticals, Licensing[ImmunoGen, sanofi-aventis, Tumor-Activated Prodrug]
Follica Announces $11M in New Financing and Expanded Team
HSMN NewsFeed,
12 Aug 2008:
Devices, Personnel, Venture Capital[Follica]
Multaq(R) (dronedarone) Granted FDA Priority Review for Patients with Atrial Fibrillation
HSMN NewsFeed,
8 Aug 2008:
Biopharmaceuticals, Cardiology, FDA[sanofi-aventis, Multaq, dronedarone, atrial fibrillation]
NewCardio Names Ihor Gussak, M.D., Ph.D., FACC Chief Medical Officer
HSMN NewsFeed,
5 Aug 2008:
Devices, Cardiology, Personnel[NewCardio]
ImmunoGen, Inc. Announces Senior Management Promotions
HSMN NewsFeed,
31 Jul 2008:
Biopharmaceuticals, Personnel[ImmunoGen]
CoLucid Pharmaceuticals Announces $25 Million Series B Financing for Advancement of First-in-Class Migraine Compound
HSMN NewsFeed,
1 Jul 2008:
Biopharmaceuticals, Venture Capital[CoLucid Pharmaceuticals]
Ceftobiprole, a new anti-MRSA broad-spectrum antibiotic, receives its first marketing authorization by Health Canada
HSMN NewsFeed,
30 Jun 2008:
Biopharmaceuticals, Regulatory[Basilea Pharmaceutica, ceftobiprole, ZEFTERA, MRSA]
FDA Approves KINRIX(TM) - New Combination Vaccine for Children
HSMN NewsFeed,
24 Jun 2008:
Biopharmaceuticals, FDA[GlaxoSmithKline, KINRIX]
BioAlliance Pharma extends its Loramyc(TM) License to China with NovaMed Pharmaceuticals
HSMN NewsFeed,
23 Jun 2008:
Biopharmaceuticals, Licensing[BioAlliance Pharma, NovaMed Pharmaceuticals, Loramyc, miconazole, Lauriad]
Alpharma Announces Changes to Executive Leadership Team
HSMN NewsFeed,
19 Jun 2008:
Biopharmaceuticals, Personnel[Alpharma]
Spectrum Pharmaceuticals Announces FUSILEV(TM) as Tradename for Levoleucovorin for Injection
HSMN NewsFeed,
17 Jun 2008:
Biopharmaceuticals[Spectrum Pharmaceuticals, FUSILEV, levoleucovorin]
Mylan Announces Tentative FDA Approval for Generic Version of Antihypertensive Avalide(R) Tablets
HSMN NewsFeed,
16 Jun 2008:
Biopharmaceuticals, Generics, FDA[Mylan, Irbesartan, Hydrochlorothiazide, Avalide, Sanofi Aventis]
Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder
HSMN NewsFeed,
10 Jun 2008:
Biopharmaceuticals[sanofi-aventis, Ambien CR, zolpidem, insomnia, major depressive disorder]
New Drug Application Filing for Levoleucovorin Tablets Completed by Spectrum Pharmaceuticals, Inc.
HSMN NewsFeed,
5 Jun 2008:
Biopharmaceuticals, Oncology, FDA[Spectrum Pharmaceuticals, Levoleucovorin, osteosarcoma]
Loic Maurel Joins Exonhit Therapeutics to Become CEO
HSMN NewsFeed,
4 Jun 2008:
Biopharmaceuticals, Personnel[ExonHit Therapeutics]
Data from Satraplatin SPARC Phase 3 Trial in Patients with Hormone-Refractory Prostate Cancer Progressing after Initial Chemotherapy Presented at 44th ASCO Annual Meeting
HSMN NewsFeed,
2 Jun 2008:
Biopharmaceuticals, Oncology[GPC Biotech, satraplatin, SPARC trial, prostate cancer]
New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data
HSMN NewsFeed,
28 May 2008:
Biopharmaceuticals, Oncology[sanofi-aventis, MOSAIC trial, Eloxatin, oxaliplatin, colon cancer]
Node-Negative Early Stage Breast Cancer Patients Benefit from Taxotere(R)-Based Chemotherapy
HSMN NewsFeed,
27 May 2008:
Biopharmaceuticals, Oncology[sanofi-aventis, GEICAM, Taxotere, breast cancer]
Nanomedicine Company Nanobiotix Elects Former Sanofi-Aventis Oncology Researcher Elsa Borghi, MD, as its Medical Director
HSMN NewsFeed,
27 May 2008:
Biopharmaceuticals, Devices, Oncology[Nanobiotix, nanoXray, nanoparticle, radiation therapy]
Landmark ATHENA Study Findings With Multaq(R)(dronedarone) Show 24% Reduction in Cardiovascular Hospitalisation or Death in Patients With Atrial Fibrillation
HSMN NewsFeed,
15 May 2008:
Biopharmaceuticals, Cardiology[Sanofi-aventis, ATHENA study, Multaq, dronedarone, atrial fibrillation]
Stable Stroke Patients More Likely to Die From a Nonstroke Cardiovascular Event Than a Further Stroke
HSMN NewsFeed,
15 May 2008:
Neurology[REACH Registry, stroke]
Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
HSMN NewsFeed,
8 May 2008:
Biopharmaceuticals, Ophthalmology[Bayer HealthCare, Regeneron Pharmaceuticals, VIEW 2 trial, AMD , VEGF Trap-Eye]
Teva Announces Global In-Market First Quarter Sales of Copaxone(R) Increased 35% to $542 Million
HSMN NewsFeed,
30 Apr 2008:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, Copaxone, multiple sclerosis]
Regeneron and Bayer HealthCare Announce Encouraging 32-Week Follow-Up Results from a Phase 2 Study of VEGF Trap-Eye in Age-Related Macular Degeneration
HSMN NewsFeed,
28 Apr 2008:
Biopharmaceuticals, Ophthalmology[Regeneron Pharmaceuticals, Bayer HealthCare, VEGF Trap-Eye, Macular Degeneration]
Nephros Strengthens Commercialization Team with Addition of Marketing Executive
HSMN NewsFeed,
21 Apr 2008:
Devices, Personnel[Nephros]
COPAXONE(R) Significantly Reduced Annual Relapse Rates and Stabilized Disease Progression in Relapsing Remitting Multiple Sclerosis Patients Failing Interferon Treatment
HSMN NewsFeed,
10 Apr 2008:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, multiple sclerosis, COPAXONE]
Collegium Pharmaceutical Announces FDA Filing for AllerNase(TM), a Nasal Inhaled Steroid for the Treatment of Allergic Rhinitis
HSMN NewsFeed,
8 Apr 2008:
Biopharmaceuticals, FDA[Collegium Pharmaceutical, AllerNase, triamcinolone acetonide, allergic rhinitis]
BioAlliance Pharma Expands Its Loramyc(TM) Franchise by Signing a South East Asia Deal Worth up to $12 Million with the Leading Korean Pharma Company Handok
HSMN NewsFeed,
31 Mar 2008:
Biopharmaceuticals, Licensing[BioAlliance Pharma, Handok Pharmaceuticals, Loramyc, miconazole Lauriad]
Positive results from Visudyne(R) combination therapy study reported at Annual Macula Society Conference
HSMN NewsFeed,
28 Mar 2008:
Biopharmaceuticals, Ophthalmology[QLT, subfoveal choroidal neovascularization, macular degeneration, Visudyne]
ARCALYST(TM) (rilonacept), First and Only FDA-approved Treatment for Cryopyrin-Associated Periodic Syndromes (CAPS), Now Available in the United States
HSMN NewsFeed,
25 Mar 2008:
Biopharmaceuticals[Regeneron Pharmaceuticals, ARCALYST, rilonacept]
Pharming signs distribution agreement for Rhucin(R) in Turkey
HSMN NewsFeed,
25 Mar 2008:
Biopharmaceuticals, Distribution[Pharming Group, Eczacibasi Group, Rhucin, Hereditary Angioedema]
Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases
HSMN NewsFeed,
20 Mar 2008:
Biopharmaceuticals, Oncology[sanofi-aventis, EORTC 40983, Eloxatin, oxaliplatin, FOLFOX4, colorectal cancer]
Predictive Biosciences Appoints Life Sciences Industry Veteran Peter Klemm, Ph.D., as Company's First President and CEO
HSMN NewsFeed,
19 Mar 2008:
Diagnostics, Personnel[Predictive Biosciences]
QLT announces positive FDA action on Aczone(TM)
HSMN NewsFeed,
17 Mar 2008:
Biopharmaceuticals[QLT, Aczone]
Sciele Pharma Acquires Twinject(R) Epinephrine Auto-Injector from Verus Pharmaceuticals
HSMN NewsFeed,
13 Mar 2008:
Biopharmaceuticals, Acquisitions[Sciele Pharma, Verus Pharmaceuticals, Twinject, epinephrine auto-injector]
OREXIGEN(TM) Therapeutics Appoints Carol Baum as Vice President of Commercialization
HSMN NewsFeed,
10 Mar 2008:
Biopharmaceuticals, Personnel[Orexigen Therapeutics]
FDA Approves New Drug Application (NDA) for LEVOleucovorin, Spectrum's First Proprietary Oncology Drug
HSMN NewsFeed,
7 Mar 2008:
Biopharmaceuticals, Oncology, FDA[Spectrum Pharmaceuticals, Levoleucovorin, methotrexate, leucovorin, osteosarcoma]
Genta Announces Licensing Agreement for Worldwide Development and Commercialization of a Leading Oral Taxane, Tesetaxel
HSMN NewsFeed,
7 Mar 2008:
Biopharmaceuticals, Licensing, Oncology[Genta , Daiichi Sankyo, tesetaxel, DJ-927]
New 300mg Loading Dose Tablet for Plavix(R) Receives Positive Opinion From the European Committee for Medicinal Products (CHMP)
HSMN NewsFeed,
5 Mar 2008:
Biopharmaceuticals, Cardiology, Regulatory[sanofi-aventis, Bristol-Myers Squibb, Plavix, Acute Coronary Syndrome]
Javelin Pharmaceuticals Board Appoints Industry Veteran Martin Driscoll as Chief Executive Officer
HSMN NewsFeed,
4 Mar 2008:
Biopharmaceuticals, Personnel[Javelin Pharmaceuticals]
Crucell Announces Vaccine Development Agreement with Wyeth Pharmaceuticals
HSMN NewsFeed,
3 Mar 2008:
Biopharmaceuticals[Crucell, Wyeth Pharmaceuticals]
FDA Approves Regeneron's ARCALYST(TM) (rilonacept) for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)
HSMN NewsFeed,
27 Feb 2008:
Biopharmaceuticals, FDA[Regeneron Pharmaceuticals, ARCALYST, rilonacept, Cryopyrin-Associated Periodic]
NPS Pharmaceuticals Announces Senior Management Changes
HSMN NewsFeed,
26 Feb 2008:
Biopharmaceuticals, Personnel[NPS Pharmaceuticals]
Sciele Expands Alliance with Sanofi-Aventis to Market Allegra(R) (Fexofenadine HCL) Orally Disintegrating Tablets (ODT) and Allegra(R) Oral Suspension (OS) in the U.S.
HSMN NewsFeed,
25 Feb 2008:
Biopharmaceuticals[Sciele Pharma, sanofi-aventis, Allegra, Fexofenadine]
FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
HSMN NewsFeed,
19 Feb 2008:
Biopharmaceuticals, FDA[UCB, sanofi-aventis, XYZAL, levocetirizine, allergic rhinitis]
Infinity and MedImmune Announce Approval for Generic Name for Novel Hsp90 Inhibitor
HSMN NewsFeed,
4 Feb 2008:
Biopharmaceuticals, Oncology[Infinity Pharmaceuticals, MedImmune, retaspimycin, heat shock protein]
NPS Pharmaceuticals Announces Board Appointments
HSMN NewsFeed,
30 Jan 2008:
Biopharmaceuticals, Personnel[NPS Pharmaceuticals]
Clexane(R)/Lovenox(R) Approved in Japan
HSMN NewsFeed,
28 Jan 2008:
Biopharmaceuticals, Regulatory[sanofi-aventis, Clexane, Lovenox, enoxaparin, venous thromboembolism, DVT]
NovaDel's New Drug Application for ZolpiMist(TM) Oral Spray to Treat Insomnia Accepted for Filing by the U.S. Food and Drug Administration
HSMN NewsFeed,
23 Jan 2008:
Biopharmaceuticals, Drug Delivery, FDA[NovaDel Pharma, ZolpiMist, zolpidem, insomnia]
Nabi Biopharmaceuticals Names Dr. Raafat E.F. Fahim as President and Chief Executive Officer
HSMN NewsFeed,
22 Jan 2008:
Biopharmaceuticals, Personnel[Nabi Biopharmaceuticals]
Steve Glass Appointed Vice President and General Manager, BioMarin Europe, Ltd.
HSMN NewsFeed,
22 Jan 2008:
Biopharmaceuticals, Personnel[BioMarin Pharmaceutical]
Dr. Manuel Worcel Appointed CEO and President of Cardiokine
HSMN NewsFeed,
22 Jan 2008:
Biopharmaceuticals, Personnel[Cardiokine]
Novexel and Forest Laboratories Announce License Agreement for NXL 104, a Novel Broad-Spectrum Beta Lactamase Inhibitor
HSMN NewsFeed,
22 Jan 2008:
Biopharmaceuticals, Licensing[Forest Laboratories, Novexel, NXL 104, beta lactamase inhibitor]
QLT reduces workforce as first step in its strategic restructure
HSMN NewsFeed,
18 Jan 2008:
Biopharmaceuticals[QLT]
Barr Confirms Patent Challenge of Eloxatin(R) Injectable, 5mg/mL
HSMN NewsFeed,
9 Jan 2008:
Biopharmaceuticals, Generics[Barr Pharmaceuticals, Barr Laboratories, Sanofi-Aventis, Eloxatin]
Follica Raises $5.5 M To Advance New Treatment for Androgenetic Alopecia Into the Clinic
HSMN NewsFeed,
4 Jan 2008:
Devices, Dermatology, Venture Capital[Follica, androgenetic alopecia, alopecia]
Ambien CR(R) (zolpidem tartrate extended-release) tablets CIV Improved Chronic Insomnia in Patients with Co-Morbid Generalized Anxiety Disorder
HSMN NewsFeed,
4 Jan 2008:
Biopharmaceuticals[sanofi-aventis, Ambien, zolpidem, insomnia, generalized anxiety disorder]
IDM Pharma Announces Termination of UVIDEM Development Collaboration and Expected Restructuring in Connection With Evaluation of Strategic Alternatives
HSMN NewsFeed,
31 Dec 2007:
Biopharmaceuticals, Oncology[IDM Pharma, sanofi-aventis, UVIDEM, melanoma]
Pharmacyclics Receives Non-Approvable Letter from the FDA for Xcytrin for the Treatment of Lung Cancer Brain Metastases
HSMN NewsFeed,
21 Dec 2007:
Biopharmaceuticals, Oncology, FDA[Pharmacyclics, Xcytrin, motexafin gadolinium, non-small cell lung cancer]
Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer
HSMN NewsFeed,
13 Dec 2007:
Biopharmaceuticals, Oncology[sanofi-aventis, Taxotere, docetaxel, cyclophosphamide, breast cancer]
Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community
HSMN NewsFeed,
5 Dec 2007:
Biopharmaceuticals[Bristol-Myers Squibb]
Early Treatment with COPAXONE(R) Demonstrated Robust Protection against Progression to Clinically Definite Multiple Sclerosis in the PreCISe Study
HSMN NewsFeed,
3 Dec 2007:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, PreCISe trial, multiple sclerosis, COPAXONE]
ImmunoGen, Inc. Hires John Tagliamonte as Vice President, Business Development
HSMN NewsFeed,
27 Nov 2007:
Biopharmaceuticals, Personnel[ImmunoGen]
Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve BP Goals
HSMN NewsFeed,
19 Nov 2007:
Biopharmaceuticals, Cardiology, FDA[Bristol-Myers Squibb, AVALIDE, irbesartan, HCTZ, hypertension]
Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
HSMN NewsFeed,
7 Nov 2007:
Biopharmaceuticals, Cardiology, Endocrinology[sanofi-aventis, insulin glargine, diabetes]
Dyax Announces the Appointment of William Pullman as Executive Vice President and Chief Development Officer
HSMN NewsFeed,
31 Oct 2007:
Biopharmaceuticals, Personnel[Dyax]
Mylan Announces Appointment of Joseph F. Haggerty as Senior Vice President and Global General Counsel
HSMN NewsFeed,
30 Oct 2007:
Biopharmaceuticals, Personnel[Mylan]
New Long-Term Analysis of Clinical Treatment Outcomes Demonstrated COPAXONE(R) is More Cost Effective Than Tysabri(R) for Treatment of Relapsing-Remitting Multiple Sclerosis
HSMN NewsFeed,
25 Oct 2007:
Biopharmaceuticals, Neurology[Teva Neuroscience, COPAXONE, glatiramer, multiple sclerosis]
Study Showed Patients Using COPAXONE(R) Had Significantly Lower Risk of Relapse and Lower Medical Costs Compared to Patients Using Rebif(R) in Relapsing-Remitting Multiple Sclerosis (RRMS)
HSMN NewsFeed,
25 Oct 2007:
Biopharmaceuticals, Neurology[Teva Neuroscience, COPAXONE, glatiramer, multiple sclerosis]
Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
HSMN NewsFeed,
24 Oct 2007:
Biopharmaceuticals, Oncology[sanofi-aventis, Taxotere, docetaxel, head and neck cancer, TAX 323, TAX 324]
New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV
HSMN NewsFeed,
24 Oct 2007:
Biopharmaceuticals[sanofi-aventis, AMBIEN CR, zolpidem, Insomnia]
COPAXONE(R) Significantly Decreases Disease Activity in Patients Who Switched from Interferon Beta (IFNb) Due to Development of Neutralizing Antibodies (NAbs)
HSMN NewsFeed,
23 Oct 2007:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, COPAXONE, Multiple Sclerosis]
Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
HSMN NewsFeed,
21 Oct 2007:
Biopharmaceuticals, Cardiology, Regulatory[sanofi-aventis, acute coronary syndrome, Plavix, clopidogrel]
Sanofi Pasteur Receives FDA Approval of Meningococcal Vaccine for Children
HSMN NewsFeed,
19 Oct 2007:
Biopharmaceuticals, FDA[sanofi-aventis, Sanofi Pasteur, Menactra, Meningococcal Vaccine]
QLT Completes Acquisition of ForSight Newco II, Inc.
HSMN NewsFeed,
18 Oct 2007:
Biopharmaceuticals, Ophthalmology, Drug Delivery[QLT, ForSight Newco II]
Long-Term Study Shows COPAXONE(R) Significantly Slows Progression of Disability and Reduces Relapse Rates in Patients with Relapsing-Remitting Multiple Sclerosis
HSMN NewsFeed,
12 Oct 2007:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, COPAXONE, glatiramer, Multiple Sclerosis]
QLT acquires leading edge ocular drug delivery system from ForSight Labs
HSMN NewsFeed,
9 Oct 2007:
Biopharmaceuticals, Ophthalmology, Drug Delivery[QLT, ForSight Newco II, ocular punctal plug]
Urigen Pharmaceuticals, Inc. Appoints Dennis H. Giesing, PhD as Chief Scientific Officer
HSMN NewsFeed,
4 Oct 2007:
Biopharmaceuticals, Urology, Personnel[Urigen Pharmaceuticals]
ImmunoGen, Inc. Hires Craig Barrows as Vice President, General Counsel and Secretary
HSMN NewsFeed,
3 Oct 2007:
Biopharmaceuticals, Personnel[ImmunoGen]
Mylan Announces Appointment of David A. Lillback as Senior Vice President and Global Head of Human Resources
HSMN NewsFeed,
1 Oct 2007:
Biopharmaceuticals, Personnel[Mylan Laboratories]
Synvista Therapeutics Appoints Carl M. Mendel, M.D. Vice president, Clinical Development and Chief Medical Officer
HSMN NewsFeed,
1 Oct 2007:
Biopharmaceuticals, Personnel[Synvista Therapeutics]
Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery
HSMN NewsFeed,
1 Oct 2007:
Biopharmaceuticals, Oncology, FDA[sanofi-aventis, Taxotere, docetaxel, head and neck cancer]
Ikaria Names Executive Vice President of Research and Development
HSMN NewsFeed,
1 Oct 2007:
Biopharmaceuticals, Personnel[Ikaria]
FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)
HSMN NewsFeed,
27 Sep 2007:
Biopharmaceuticals, Cardiology, FDA[Bristol-Myers Squibb, Acute Coronary Syndrome, PLAVIX, clopidogrel]
Paramount BioSciences Appoints Business Development Vice President
HSMN NewsFeed,
26 Sep 2007:
Biopharmaceuticals, Personnel[Paramount BioSciences]
Osprey Pharmaceuticals Names Jack M. Anthony as CEO
HSMN NewsFeed,
26 Sep 2007:
Biopharmaceuticals, Personnel[Osprey Pharmaceuticals]
Barr Confirms Patent Challenge of UROXATRAL(R)
HSMN NewsFeed,
25 Sep 2007:
Biopharmaceuticals, Generics, Litigation[Barr Pharmaceuticals, UROXATRAL, alfuzosin, sanofi-aventis]
Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes
HSMN NewsFeed,
25 Sep 2007:
Biopharmaceuticals, Oncology[Eli Lilly, non-small cell lung cancer, ALIMTA , pemetrexed]
Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
HSMN NewsFeed,
20 Sep 2007:
Biopharmaceuticals[Vical Inc, NV1FGF, angiogenesis therapy, TAMARIS, critical limb ischemia]
New Data Show That GlaxoSmithKline's Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
HSMN NewsFeed,
19 Sep 2007:
Biopharmaceuticals[GlaxoSmithKline, Rotarix, rotavirus]
New Data Support Long-Term Efficacy and Safety in Patients Who Took Exubera for Eight Years
HSMN NewsFeed,
18 Sep 2007:
Biopharmaceuticals, Endocrinology[Pfizer, Exubera, insulin, Inhalation Powder, diabetes]
Crucell Appoints Mr. Cees de Jong as Chief Operating Officer
HSMN NewsFeed,
10 Sep 2007:
Biopharmaceuticals, Personnel[Crucell]
The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
HSMN NewsFeed,
5 Sep 2007:
Biopharmaceuticals, Cardiology[sanofi-aventis, EURIDIS, ADONIS , dronedarone, MULTAQ, atrial fibrillation]
Pharmacyclics Announces Encouraging Phase 2 Data With Xcytrin(R) in Recurrent Non-Small Cell Lung Cancer Patients
HSMN NewsFeed,
5 Sep 2007:
Biopharmaceuticals, Oncology[Pharmacyclics, Xcytrin, motexafin gadolinium, non-small cell lung cancer]
REACH Registry Highlights That Patients With Peripheral Arterial Disease (PAD) Suffer High Rates of Heart Attack, Stroke, Hospitalization, and Death
HSMN NewsFeed,
5 Sep 2007:
Cardiology[REACH Registry, atherothrombosis, peripheral arterial disease]
New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
HSMN NewsFeed,
2 Sep 2007:
Biopharmaceuticals, Cardiology[sanofi-aventis, Lovenox, enoxaparin, Acute Coronary Syndrome]
Eligard(R) six-month formulation successfully completes European approval procedure
HSMN NewsFeed,
31 Aug 2007:
Biopharmaceuticals, Drug Delivery, Regulatory, Oncology[QLT, Eligard, leuprolide, Atrigel, prostate cancer]
Neuro-Hitech Announces the Appointment of Dr. Gary Shearman as President and Chief Executive Officer
HSMN NewsFeed,
28 Aug 2007:
Biopharmaceuticals, Personnel[Neuro-Hitech]
Phase 3 Oncology Program for Aflibercept (VEGF Trap) Initiated by Regeneron and sanofi-aventis
HSMN NewsFeed,
23 Aug 2007:
Biopharmaceuticals, Oncology[Regeneron Pharmaceuticals, sanofi-aventis, aflibercept, VEGF Trap]
Collegium Pharmaceutical Provides Update on Development of its Nasal Inhaled Steroid for Allergic Rhinitis
HSMN NewsFeed,
15 Aug 2007:
Biopharmaceuticals[Collegium Pharmaceutical, Tri-Nasal, triamcinolone, allergic rhinitis]
Theratechnologies Appoints Dr. Pierre Caudrelier as Chief Medical Officer
HSMN NewsFeed,
9 Aug 2007:
Biopharmaceuticals, Personnel[Theratechnologies]
Rilonacept (IL-1 Trap) Granted FDA Priority Review for the Treatment of CAPS
HSMN NewsFeed,
8 Aug 2007:
Biopharmaceuticals[Regeneron Pharmaceuticals, rilonacept, Interleukin-1 trap]
Regeneron and Bayer HealthCare Initiate Phase 3 Global Development Program For VEGF Trap-Eye In Wet Age-Related Macular Degeneration (AMD)
HSMN NewsFeed,
2 Aug 2007:
Biopharmaceuticals, Ophthalmology[Regeneron Pharmaceuticals, Bayer HealthCare, VEGF Trap]
SoloSTAR(R), the First Prefilled Disposable Insulin Pen for Lantus(R), is Now Available in the United States
HSMN NewsFeed,
30 Jul 2007:
Biopharmaceuticals, Endocrinology, Drug Delivery[sanofi-aventis, Lantus, SoloSTAR, insulin pen, diabetes]
ImmunoGen, Inc. Announces Departure of Pauline Jen Ryan
HSMN NewsFeed,
26 Jul 2007:
Biopharmaceuticals, Personnel[ImmunoGen]
Spectrum Pharmaceuticals Acquires From Indena Worldwide Rights To Ortataxel, A Phase 2 Third Generation Taxane
HSMN NewsFeed,
25 Jul 2007:
Biopharmaceuticals, Oncology, Licensing[Spectrum Pharmaceuticals, Indena S.p.A., ortataxel, taxane]
QLT announces FDA filing and review of Aczone(TM) labeling supplement for removal of blood screening requirement
HSMN NewsFeed,
23 Jul 2007:
Biopharmaceuticals, Dermatology, FDA[QLT, Aczone, acne]
Ortec International: Dr. Costa Papastephanou Appointed CEO
HSMN NewsFeed,
11 Jul 2007:
Regenerative Medicine, Wound Care, Personnel[Ortec International, stem cell]
Trius Therapeutics Recruits Former J&J Clinician as Chief Medical Officer
HSMN NewsFeed,
11 Jul 2007:
Biopharmaceuticals, Personnel[Trius Therapeutics, antibiotic]
New Study Shows That Extending Prophylaxis With Clexane(R) / Lovenox(R) (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
HSMN NewsFeed,
8 Jul 2007:
Biopharmaceuticals[Sanofi-aventis, EXCLAIM study, Clexane, Lovenox, venous thromboembolism, VTE]
NPS Appoints Francois Nader, M.D., to Executive Vice President and COO
HSMN NewsFeed,
3 Jul 2007:
Biopharmaceuticals, Personnel[NPS Pharmaceuticals]
NicOx appoints Pascal Pfister MD as Chief Scientific Officer and strengthens R&D organization
HSMN NewsFeed,
2 Jul 2007:
Biopharmaceuticals, Personnel[NICOX]
Rimonabant Regulatory Update in the United States
HSMN NewsFeed,
29 Jun 2007:
Biopharmaceuticals[sanofi-aventis, Acomplia, rimonabant, obesity]
Coley Pharmaceutical Group Grants Dynavax License for Commercialization of HEPLISAV(TM)
HSMN NewsFeed,
28 Jun 2007:
Biopharmaceuticals, Licensing[Coley Pharmaceutical, Dynavax Technologies, HEPLISAV, hepatitis B, vaccine]
Advancis Pharmaceutical Changes Its Name to MiddleBrook Pharmaceuticals, Inc.
HSMN NewsFeed,
28 Jun 2007:
Biopharmaceuticals[MiddleBrook Pharmaceuticals, Advancis Pharmaceutical, PULSYS]
Taxotere(R) (docetaxel) Granted FDA Priority Review for Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck Prior to Chemoradiotherapy and Surgery
HSMN NewsFeed,
27 Jun 2007:
Biopharmaceuticals, FDA, Oncology[Sanofi-aventis, Taxotere, docetaxel, head and neck cancer]
MAP Pharmaceuticals Appoints Bernard J. Kelley to Board of Directors
HSMN NewsFeed,
26 Jun 2007:
Biopharmaceuticals, Drug Delivery, Personnel[MAP Pharmaceuticals]
Results of Two Head-to-Head Studies Demonstrated Long-Acting Insulin Lantus(R) Lowered Free Fatty Acid Levels Equal to or Better Than Thiazolidinediones
HSMN NewsFeed,
23 Jun 2007:
Biopharmaceuticals, Endocrinology[sanofi-aventis, Lantus, insulin glargine, diabetes]
Coley Pharmaceutical Group Announces Pfizer's Discontinuation of Clinical Trials for PF-3512676 Combined with Cytotoxic Chemotherapy in Advanced Non Small Cell Lung Cancer
HSMN NewsFeed,
20 Jun 2007:
Biopharmaceuticals, Oncology[Coley Pharmaceutical Group, Pfizer, PF-3512676, lung cancer]
Sanofi-Aventis and Bristol-Myers Squibb Prevail in U.S. Plavix Patent Litigation
HSMN NewsFeed,
19 Jun 2007:
Biopharmaceuticals, Generics, Litigation[Bristol-Myers Squibb, Sanofi-aventis, clopidogrel, Plavix, Apotex]
Health Canada approves new chemotherapy treatment for patients with metastatic colorectal cancer
HSMN NewsFeed,
18 Jun 2007:
Biopharmaceuticals, Oncology, Regulatory[sanofi-aventis, Eloxatin, oxaliplatin, colorectal cancer]
FDA Approves New Route of Administration for Rapid-Acting Apidra(R) Providing an Additional Treatment Option for Hospitalized Diabetes Patients with High Blood Sugar Levels
HSMN NewsFeed,
15 Jun 2007:
Biopharmaceuticals, Endocrinology[sanofi-aventis, Apidra, glulisine, insulin, diabetes]
Seattle Genetics Adds Industry Veterans John P. McLaughlin and Daniel G. Welch to its Board of Directors and Promotes Eric Dobmeier to Chief Business Officer
HSMN NewsFeed,
14 Jun 2007:
Biopharmaceuticals, Oncology, Personnel[Seattle Genetics]
FDA Advisory Committee Did Not Recommend Approval of Rimonabant (ZIMULTI(R)) for Use in Obese and Overweight Patients With Associated Risks Factors
HSMN NewsFeed,
13 Jun 2007:
Biopharmaceuticals, FDA, Endocrinology[sanofi-aventis, rimonabant, ZIMULTI, ACOMPLIA]
ARIAD Announces Appointment of Senior Oncology Executive to Leadership Team
HSMN NewsFeed,
13 Jun 2007:
Biopharmaceuticals, Personnel[ARIAD Pharmaceuticals]
Sciele Pharma Completes Acquisition of Alliant Pharmaceuticals
HSMN NewsFeed,
12 Jun 2007:
Biopharmaceuticals, Mergers & Acquisitions[Sciele Pharma, Alliant Pharmaceuticals, Morton Grove Pharmaceuticals]
Coley Pharmaceutical Group Broadens Leading Toll-like Receptor (TLR) Platform Through Strategic Acquisition of 3M Company's TLR Therapeutic Research and Development Programs
HSMN NewsFeed,
11 Jun 2007:
Biopharmaceuticals, Oncology, Acquisitions[Coley Pharmaceutical Group, 3M]
Regeneron Submits Biologics License Application to U.S. FDA for IL-1 Trap (Rilonacept) for Treatment of CAPS
HSMN NewsFeed,
8 Jun 2007:
Biopharmaceuticals[Regeneron Pharmaceuticals, Interleukin-1 Trap, rilonacept]
COPAXONE(R) Pre-Filled Syringe Can Now Be Stored for up to One Month at Room Temperature
HSMN NewsFeed,
6 Jun 2007:
Biopharmaceuticals, FDA, Neurology[Teva Pharmaceutical, COPAXONE, glatiramer, Multiple Sclerosis]
Health Canada's approval of an expanded indication for PLAVIX(R) (clopidogrel bisulfate) now offers protection from all types of heart attacks
HSMN NewsFeed,
5 Jun 2007:
Biopharmaceuticals, Cardiology, Regulatory[sanofi-aventis, Bristol-Myers Squibb, Plavix, clopidogrel]
Updated Study Results Reinforce Survival Benefit of Taxotere(R) (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
HSMN NewsFeed,
4 Jun 2007:
Biopharmaceuticals, Oncology[sanofi-aventis, Taxotere, docetaxel, prostate cancer]
Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
HSMN NewsFeed,
4 Jun 2007:
Biopharmaceuticals, Oncology[Pharmion, GPC Biotech, satraplatin, prostate cancer]
Eloxatin(R) (oxaliplatin injection)-Based Chemotherapy Sets New Treatment Benchmark in Patients With Metastatic Colorectal Cancer
HSMN NewsFeed,
4 Jun 2007:
Biopharmaceuticals, Oncology[sanofi-aventis, FOLFOX4, Eloxatin, oxaliplatin, Colorectal Cancer]
The Eloxatin(R)-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer
HSMN NewsFeed,
4 Jun 2007:
Biopharmaceuticals, Oncology[sanofi-aventis, FOLFOX4, Eloxatin, oxaliplatin, liver metastases]
S-1, a Novel Oral Fluoropyrimidine, When Combined With Cisplatin, Demonstrates Significant Improvement in Overall Survival of Advanced Gastric Cancer Patients Over S-1 Alone
HSMN NewsFeed,
3 Jun 2007:
Biopharmaceuticals, Oncology[sanofi-aventis, fluoropyrimidine, Gastric Cancer]
ImmunoGen, Inc. Announces Clinical Data Reported at ASCO
HSMN NewsFeed,
3 Jun 2007:
Biopharmaceuticals, Drug Delivery, Oncology[ImmunoGen, Tumor-Activated Prodrug]
FOLFOX4 (Eloxatin(R)-based Chemotherapy) After Surgery Improves Overall Survival in Patients With Early (Stage III) Colon Cancer
HSMN NewsFeed,
3 Jun 2007:
Biopharmaceuticals, Oncology[sanofi-aventis, FOLFOX4, Eloxatin, oxaliplatin, colorectal cancer]
Oxford Biomedica and Sanofi-Aventis Report new TroVax(R) Phase II Trial Results in Renal Cancer
HSMN NewsFeed,
3 Jun 2007:
Biopharmaceuticals, Oncology[sanofi-aventis, Oxford BioMedica , TroVax, renal cell carcinoma]
Clinical Data Suggest Potential Versatility of ALIMTA(R) (Pemetrexed for Injection)-Based Regimens in Lung Cancer
HSMN NewsFeed,
2 Jun 2007:
Biopharmaceuticals, Oncology[Eli Lilly, ALIMTA, pemetrexed, non-small cell lung cancer]
ABRAXANE Demonstrates Longer Progression-Free Survival versus Taxotere in the Treatment of First-Line Metastatic Breast Cancer
HSMN NewsFeed,
2 Jun 2007:
Biopharmaceuticals, Oncology[Abraxis BioScience, ABRAXANE, paclitaxel, Breast Cancer]
New Data Highlighting ABRAXANE as Single Agent and in Combination for the Treatment of Breast, Lung and Ovarian Cancers to Be Presented at ASCO
HSMN NewsFeed,
30 May 2007:
Biopharmaceuticals, Drug Delivery, Oncology[Abraxis BioScience, ABRAXANE, paclitaxel]
BrainCells Names Seth D. Goldblum VP, Business Development
HSMN NewsFeed,
30 May 2007:
Biopharmaceuticals, Neurology, Personnel[BrainCells]
FDA Approves XYZAL(R) (Levocetirizine Dihydrochloride) Tablets for the Relief of Seasonal and Year Round Allergies, and Chronic Hives
HSMN NewsFeed,
29 May 2007:
Biopharmaceuticals, FDA[UCB, sanofi-aventis, XYZAL, levocetirizine]
NeurogesX Appoints BioMarin CEO Bienaime as Chairman
HSMN NewsFeed,
29 May 2007:
Biopharmaceuticals, Personnel[NeurogesX]
QLT USA, Inc. files Aczone(TM) labeling supplement for removal of blood screening requirement
HSMN NewsFeed,
29 May 2007:
Biopharmaceuticals, Dermatology, Regulatory[QLT, Aczone, acne]
IDM Pharma Names Timothy P. Walbert as President and CEO
HSMN NewsFeed,
29 May 2007:
Biopharmaceuticals, Personnel[IDM Pharma]
Talabostat Clinical Program Put on Clinical Hold by FDA
HSMN NewsFeed,
21 May 2007:
Biopharmaceuticals, Oncology[Point Therapeutics, talabostat, non small cell lung cancer]
FDA Approves Lovenox(R) (Enoxaparin Sodium Injection) for the Most Severe Type of Heart Attack
HSMN NewsFeed,
18 May 2007:
Biopharmaceuticals, Cardiology, FDA[sanofi-aventis, Lovenox, Low Molecular Weight Heparin, enoxaparin]
Ranbaxy Receives Tentative FDA Approval for Fexofenadine Hydrochloride Tablets
HSMN NewsFeed,
17 May 2007:
Biopharmaceuticals, Generics, FDA[Ranbaxy Pharmaceuticals, Fexofenadine, sanofi-aventis, Allegra]
Point Therapeutics Announces Interim Analysis to be Performed on Its Phase 3 Talabostat with Alimta Study
HSMN NewsFeed,
15 May 2007:
Biopharmaceuticals, Oncology[Point Therapeutics, talabostat]
Bristol-Myers Squibb Announces Agreement in Principle to Resolve Federal Antitrust Investigation
HSMN NewsFeed,
10 May 2007:
Biopharmaceuticals[Bristol-Myers Squibb, sanofi-aventis, Apotex, Plavix]
FDA Advisory Committee Reviews Data on IDM Pharma's Junovan(TM) (mifamurtide) for Treatment of Osteosarcoma
HSMN NewsFeed,
9 May 2007:
Biopharmaceuticals, Oncology, FDA[IDM Pharma, INT 0133, Junovan, mifamurtide, osteosarcoma]
VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual Meeting
HSMN NewsFeed,
9 May 2007:
Biopharmaceuticals, Ophthalmology[Regeneron Pharmaceuticals, VEGF Trap, macular degeneration, macular edema]
Treatment with COPAXONE(R) Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis
HSMN NewsFeed,
4 May 2007:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, COPAXONE, glatiramer, minocycline, multiple sclerosis]
IDM Pharma Appoints Robert De Vaere as Senior Vice President and CFO
HSMN NewsFeed,
4 May 2007:
Biopharmaceuticals, Personnel[IDM Pharma]
COPAXONE(R) Treatment over Two Years after Short Term Induction with Mitoxantrone Provided Sustained Benefits to Active Relapsing-Remitting Multiple Sclerosis Patients
HSMN NewsFeed,
4 May 2007:
Biopharmaceuticals, Neurology[Teva Neuroscience, multiple sclerosis, COPAXONE, glatiramer]
Viron Therapeutics Appoints Claude Benedict, M.D. as New Senior Vice President, Clinical Development and Regulatory Affairs
HSMN NewsFeed,
1 May 2007:
Biopharmaceuticals, Personnel[Viron Therapeutics]
QLT strengthens its expertise in ocular by adding David A. Saperstein M.D. as interim Chief Medical Officer and Paul L. Kaufman M.D. as Head of the Ocular Scientific Advisory Board
HSMN NewsFeed,
1 May 2007:
Biopharmaceuticals, Personnel[QLT]
FDA Approves Lantus SoloStar(R) - A New Prefilled Disposable Insulin Pen For Use With LANTUS(R) In People With Type 1 And Type 2 Diabetes
HSMN NewsFeed,
30 Apr 2007:
Biopharmaceuticals, Endocrinology, Drug Delivery, FDA[sanofi-aventis, Lantus SoloStar, insulin pen, diabetes]
NicOx recruits Sanjiv Sharma as Vice President Commercial Affairs in the United States
HSMN NewsFeed,
30 Apr 2007:
Biopharmaceuticals, Personnel[NICOX]
Ranbaxy Receives Final Approval to Manufacture and Market Zolpidem Tablets for Insomnia
HSMN NewsFeed,
26 Apr 2007:
Biopharmaceuticals, Generics, FDA[Ranbaxy, Zolpidem, Ambien , sanofi-aventis]
Dr. Reddy's Announces the Launch of Zolpidem Tartrate Tablets
HSMN NewsFeed,
25 Apr 2007:
Biopharmaceuticals, Generics, FDA[Dr. Reddy's Laboratories, Zolpidem, Sanofi-Aventis, Ambien]
Roxane Laboratories, Inc. Announces Launch of Zolpidem Tartrate Tablets CIV, 5mg and 10mg
HSMN NewsFeed,
24 Apr 2007:
Biopharmaceuticals, Generics[Roxane Laboratories, Zolpidem, AMBIEN, Sanofi-Aventis]
Prasco Enters into Agreement with sanofi-aventis to Market the Authorized Generic Versions of Ambien(R) (Zolpidem Tartrate) CIV
HSMN NewsFeed,
23 Apr 2007:
Biopharmaceuticals, Generics, Distribution[Prasco Laboratories, sanofi-aventis, Zolpidem, Ambien]
Caraco Pharmaceutical Laboratories Ltd. Announces FDA Approval to Market Generic Ambien(R)
HSMN NewsFeed,
23 Apr 2007:
Biopharmaceuticals, Generics, FDA[Caraco Pharmaceutical, Zolpidem, Ambien, sanofi-aventis]
Mylan Announces Final FDA Approval and Immediate Shipment of Zolpidem Tartrate Tablets
HSMN NewsFeed,
23 Apr 2007:
Biopharmaceuticals, Generics, FDA[Mylan Laboratories, Mylan Pharmaceuticals, Zolpidem, Sanofi-Aventis, Ambien]
The Lancet Publishes PREVAIL Study Results Showing Lovenox(R) Superiority Over Unfractionated Heparin for Reducing the Risk of Venous ThromboEmbolism in Patients With Acute Ischemic Stroke
HSMN NewsFeed,
20 Apr 2007:
Biopharmaceuticals[sanofi-aventis, PREVAIL trial, VTE , Enoxaparin, Clexane, Lovenox]
Vasogen and Grupo Ferrer Form Collaboration to Commercialize Celacade(TM) in the European Union
HSMN NewsFeed,
18 Apr 2007:
Biopharmaceuticals, Devices, Cardiology[Vasogen, Grupo Ferrer, Celacade]
FDA Licenses First U.S. Vaccine for Humans Against Avian Influenza
HSMN NewsFeed,
17 Apr 2007:
Biopharmaceuticals, Licensing[sanofi-aventis, sanofi pasteur, H5N1 vaccine, avian influenza vaccine]
Data Published in Neurology Showed That Higher Dose of COPAXONE(R) Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS)
HSMN NewsFeed,
17 Apr 2007:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, COPAXONE, Multiple Sclerosis]
Coley Pharmaceutical Group Licenses VaxImmune(TM) to Merck for Use in Vaccine Programs
HSMN NewsFeed,
12 Apr 2007:
Biopharmaceuticals, Licensing[Coley Pharmaceutical Group, Merck, VaxImmune]
First Pharmacoeconomic Analysis with Long-Term Data Showed COPAXONE(R) Was More Cost-Effective Than Interferon Beta Therapies for Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)
HSMN NewsFeed,
11 Apr 2007:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, COPAXONE, glatiramer, Interferon, multiple sclerosis]
Coley Pharmaceutical Group Announces Completion of Patient Enrollment in Pfizer's Two Pivotal Phase III NSCLC Clinical Trials
HSMN NewsFeed,
10 Apr 2007:
Biopharmaceuticals, Oncology[Coley Pharmaceutical, Pfizer, Toll-like receptor, TLR9, NSCLC, lung cancer]
Emisphere Technologies, Inc. Appoints Michael V. Novinski as President and Chief Executive Officer
HSMN NewsFeed,
10 Apr 2007:
Biopharmaceuticals, Drug Delivery, Personnel[Emisphere Technologies]
Alpharma Announces New Sales and Marketing Leadership in its Pharmaceuticals Business
HSMN NewsFeed,
9 Apr 2007:
Biopharmaceuticals, Personnel[Alpharma]
Barr Confirms Patent Challenge of Ambien CR(R)
HSMN NewsFeed,
6 Apr 2007:
Biopharmaceuticals, Generics, FDA, Litigation[Barr Pharmaceuticals, sanofi-aventis, Ambien CR, Zolpidem]
Sculptra(TM), new cosmetic dermatology treatment, creates long-lasting, natural-looking results
HSMN NewsFeed,
4 Apr 2007:
Biopharmaceuticals, Dermatology[sanofi-aventis, Sculptra]
USDA Grants Conditional Approval for First Therapeutic Vaccine to Treat Cancer
HSMN NewsFeed,
26 Mar 2007:
Biopharmaceuticals, Oncology, Regulatory[Merial US, canine melanoma]
Data Shows That Omission of Venous Thromboembolism (VTE) Prophylaxis in Hospitalized Medical Patients Is Frequent and Leads to Higher Risk of Deep-Vein Thrombosis (DVT)
HSMN NewsFeed,
25 Mar 2007:
Biopharmaceuticals, Cardiology[sanofi-aventis, venous thromboembolism, Deep-Vein Thrombosis, DVT]
Novavax Appoints James Robinson Vice President of Technical and Quality Operations
HSMN NewsFeed,
14 Mar 2007:
Biopharmaceuticals, Personnel[Novavax]
Sanofi-Aventis Debuts AgingWithBeauty.com
HSMN NewsFeed,
12 Mar 2007:
Biopharmaceuticals, Dermatology[sanofi-aventis, Dermik Laboratories]
Novavax Board of Directors Elect John Lambert as Executive Chairman
HSMN NewsFeed,
8 Mar 2007:
Biopharmaceuticals, Personnel[Novavax]
ImmunoGen, Inc. Announces Departure of Walter Blattler
HSMN NewsFeed,
6 Mar 2007:
Biopharmaceuticals, Personnel[ImmunoGen]
Point Therapeutics Provides Clinical Update
HSMN NewsFeed,
1 Mar 2007:
Biopharmaceuticals, Oncology[Point Therapeutics, talabostat]
Post-Hoc Data Analyses Published in Annals of Neurology Found COPAXONE(R) Significantly Delayed Accumulated Disability in Male Patients with Primary Progressive Multiple Sclerosis (PPMS)
HSMN NewsFeed,
27 Feb 2007:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, COPAXONE, glatiramer, multiple sclerosis]
Ipsen: Appointment of Stephane Thiroloix as Executive Vice-President, Corporate Development
HSMN NewsFeed,
26 Feb 2007:
Biopharmaceuticals, Personnel[Ipsen]
Phase 2 Results of Genasense(R) Plus Chemotherapy in Advanced Prostate Cancer Reported at Cancer Conference
HSMN NewsFeed,
23 Feb 2007:
Biopharmaceuticals, Oncology[Genta , Genasense, oblimersen, prostate cancer]
Satraplatin Shown to Significantly Reduce Risk of Disease Progression in Advanced Hormone-Refractory Prostate Cancer Patients
HSMN NewsFeed,
23 Feb 2007:
Biopharmaceuticals, Oncology[Pharmion, GPC Biotech, SPARC trial, satraplatin, prostate cancer]
Spectrum Pharmaceuticals Announces Satraplatin Data Presentation at the American Society of Clinical Oncology Prostate Cancer Symposium
HSMN NewsFeed,
23 Feb 2007:
Biopharmaceuticals, Oncology[Spectrum Pharmaceuticals, SPARC trial, satraplatin, prostate cancer]
Idera Pharmaceuticals Appoints Dr. Alice Bexon, Vice President of Clinical Development
HSMN NewsFeed,
21 Feb 2007:
Biopharmaceuticals, Personnel[Idera Pharmaceuticals]
Maxygen Appoints Santosh Vetticaden, M.D., Ph.D., as Chief Medical Officer
HSMN NewsFeed,
21 Feb 2007:
Biopharmaceuticals, Personnel[Maxygen]
Stem Cell Sciences Licenses Neural Stem Cell Technology to Merck & Co., Inc.
HSMN NewsFeed,
20 Feb 2007:
Biopharmaceuticals, Regenerative Medicine, Licensing[Stem Cell Sciences, Merck, stem cell]
sanofi-aventis Announces Update to U.S. Prescribing Information for Ketek(R) (Telithromycin)
HSMN NewsFeed,
12 Feb 2007:
Biopharmaceuticals, FDA[sanofi-aventis, Ketek, telithromycin]
FDA Grants Priority Review to Lovenox(R) (Enoxaparin Sodium Injection) Supplemental New Drug Application (sNDA) for Acute Heart Attack
HSMN NewsFeed,
7 Feb 2007:
Biopharmaceuticals, Cardiology[Sanofi-aventis, Lovenox, enoxaparin, STEMI , acute heart attack]
Tim Rothwell Appointed Chairman of Sanofi-aventis Group U.S. Pharmaceutical Activities
HSMN NewsFeed,
6 Feb 2007:
Biopharmaceuticals, Personnel[sanofi-aventis]
AstraZeneca Licenses Regeneron's VelocImmune(R) Technology for Discovering Human Monoclonal Antibodies
HSMN NewsFeed,
5 Feb 2007:
Biopharmaceuticals, Licensing[Regeneron Pharmaceuticals, AstraZeneca]
Sanofi-aventis Applauds New National Standards for Prophylaxis of Venous Thromboembolism in Surgical Patients
HSMN NewsFeed,
1 Feb 2007:
Biopharmaceuticals[sanofi-aventis, VTE, venous thromboembolism, pulmonary embolism]
YM BioSciences announces termination of the tesmilifene Phase III pivotal trial in advanced breast cancer
HSMN NewsFeed,
30 Jan 2007:
Biopharmaceuticals, Oncology[YM BioSciences, tesmilifene, breast cancer]
NCCN Updates Colon Cancer Guidelines
HSMN NewsFeed,
29 Jan 2007:
Biopharmaceuticals, Oncology[NCCN, capecitabine, Xeloda, Roche , oxaliplatin, Eloxatin, sanofi-aventis]
Coley Pharmaceutical Group Updates Hepatitis C Drug Development Strategy
HSMN NewsFeed,
22 Jan 2007:
Biopharmaceuticals[Coley Pharmaceutical, ACTILON, Hepatitis C, TLR Therapeutics]
Genentech Announces Senior Vice President and Vice President Promotions in Commercial, Legal and Product Operations
HSMN NewsFeed,
17 Jan 2007:
Biopharmaceuticals, Personnel[Genentech]
Labopharm Provides Update on Roll Out of Once-daily Tramadol Across Europe
HSMN NewsFeed,
9 Jan 2007:
Biopharmaceuticals[Labopharm, tramadol, Unitrama]
Urigen N.A., Inc. Appoints Dennis Giesing, PhD As Director of Product Development
HSMN NewsFeed,
8 Jan 2007:
Biopharmaceuticals, Urology, Personnel[Urigen N.A.]
Kosan Appoints Jane Green as Vice President, Corporate Communications
HSMN NewsFeed,
3 Jan 2007:
Biopharmaceuticals, Personnel[Kosan Biosciences]
IDM Pharma Announces Acceptance for Review of the NDA for Junovan(TM) (Mifamurtide)
HSMN NewsFeed,
26 Dec 2006:
Biopharmaceuticals, Oncology[IDM Pharma, Junovan, mifamurtide, osteosarcoma]
ImmunoGen, Inc. Announces that sanofi-aventis Has Entered into an Option Agreement for Expanded Access to the Company's TAP Technology
HSMN NewsFeed,
26 Dec 2006:
Biopharmaceuticals, Drug Delivery, Licensing[ImmunoGen, Tumor-Activated Prodrug, sanofi-aventis]
Regeneron Reports Blocking New Angiogenesis Target May Offer Novel Approach to Slowing Tumor Growth
HSMN NewsFeed,
20 Dec 2006:
Biopharmaceuticals, Oncology[Regeneron Pharmaceuticals, Dll4, angiogenesis]
Sanofi pasteur Influenza Vaccine Production Tops 170 Million Doses in 2006
HSMN NewsFeed,
20 Dec 2006:
Biopharmaceuticals[sanofi pasteur, sanofi-aventis, influenza vaccine]
New Study Shows Clexane(R) / Lovenox(R) (Enoxaparin Sodium Injection) is More Effective Than Unfractionated Heparin (UFH) for Preventing the Risk of Venous Thromboembolism (VTE) in Patients With Acute Ischemic Stroke
HSMN NewsFeed,
12 Dec 2006:
Biopharmaceuticals[sanofi-aventis, Clexane, Lovenox, Enoxaparin, Venous Thromboembolism]
New Study Shows Lovenox(R) (Enoxaparin Sodium Injection) Is More Effective Than Unfractionated Heparin (UFH) for Lowering the Risk of Venous Thromboembolism (VTE) in Patients With Acute Ischemic Stroke
HSMN NewsFeed,
12 Dec 2006:
Biopharmaceuticals[sanofi-aventis, Lovenox, Enoxaparin, Venous Thromboembolism, stroke]
Alliant Pharmaceuticals Signs Co-Promotion Agreement With sanofi-aventis for Allegra(R) (fexofenadine hydrochloride) Oral Suspension
HSMN NewsFeed,
11 Dec 2006:
Biopharmaceuticals[Alliant Pharmaceuticals, sanofi-aventis, Allegra, fexofenadine]
Abraxis BioScience to Present Data from Six Studies at San Antonio Breast Cancer Symposium
HSMN NewsFeed,
11 Dec 2006:
Biopharmaceuticals, Oncology[Abraxis BioScience, ABRAXANE, paclitaxel, Breast Cancer]
Coley Pharmaceutical Amends Strategic Alliance License Agreement With GlaxoSmithKline for VaxImmune(TM) Vaccine Adjuvant
HSMN NewsFeed,
8 Dec 2006:
Biopharmaceuticals, Licensing[Coley Pharmaceutical, GlaxoSmithKline, VaxImmune]
Rimonabant Update in the United States
HSMN NewsFeed,
8 Dec 2006:
Biopharmaceuticals, Endocrinology, FDA[sanofi-aventis, Rimonabant, ACOMPLIA , diabetes]
Indevus and Sanofi-Aventis' Spin-Out Company, Novexel, Announce Out-licensing of Aminocandin Anti-fungal
HSMN NewsFeed,
5 Dec 2006:
Biopharmaceuticals, Licensing[Indevus Pharmaceuticals, Novexel, Aminocandin]
NovaDel Appoints David Bergstrom as Chief Operating Officer
HSMN NewsFeed,
5 Dec 2006:
Biopharmaceuticals, Personnel[NovaDel Pharma]
New Data Shows Rimonabant Benefited Patients with Type 2 Diabetes by Improving Blood Sugar Control, Reducing Weight and Acting on Other Cardiometabolic Risk Factors
HSMN NewsFeed,
5 Dec 2006:
Biopharmaceuticals, Endocrinology, Cardiology[sanofi-aventis, rimonabant, SERENADE study, diabetes]
Millennium Initiates Phase II Trial to Evaluate MLN3897 in Rheumatoid Arthritis
HSMN NewsFeed,
28 Nov 2006:
Biopharmaceuticals[Millennium Pharmaceuticals, MLN3897, sanofi-aventis, rheumatoid arthritis]
Hemispherx Biopharma Hires New President/Chief Operating Officer to Lead the Company's Drive to Commercialization
HSMN NewsFeed,
28 Nov 2006:
Biopharmaceuticals, Personnel[Hemispherx Biopharma, Anthony A. Bonelli]
Artes Medical Names Diane S. Goostree President and Chief Executive Officer
HSMN NewsFeed,
28 Nov 2006:
Devices, Personnel[Artes Medical]
Intradigm Announces Significant Enhancements of the Company Capabilities, a New Series A Financing and Important Addition to Senior Management Team
HSMN NewsFeed,
21 Nov 2006:
Biopharmaceuticals, Personnel, Venture Capital[Intradigm, RNA interference]
IDM Pharma Submits Filing for European Market Approval of Mepact(TM) (mifamurtide, Junovan(TM) in the US) in the Treatment of Osteosarcoma
HSMN NewsFeed,
7 Nov 2006:
Biopharmaceuticals, Oncology, Regulatory[IDM Pharma, Mepact, mifamurtide, osteosarcoma]
Advancis Pharmaceutical Submits Proposed Order in Corporate Name Infringement Lawsuit
HSMN NewsFeed,
31 Oct 2006:
Biopharmaceuticals, Litigation[Advancis Pharmaceutical, sanofi-aventis]
EyeGate Pharma Starts U.S. Operations in Waltham, MA
HSMN NewsFeed,
30 Oct 2006:
Biopharmaceuticals, Ophthalmology, Personnel[EyeGate Pharma, Stephen From]
New Study Shows Sculptra(R) (injectable poly-L-lactic acid), a Unique Class of Injectable for Cosmetic Use, Provides 13 Month Results
HSMN NewsFeed,
30 Oct 2006:
Biopharmaceuticals, Dermatology[Dermik Laboratories, sanofi-aventis, Sculptra, poly-L-lactic acid]
IDM Pharma Submits New Drug Application to the FDA for Junovan(TM) (mifamurtide) in the Treatment of Osteosarcoma
HSMN NewsFeed,
26 Oct 2006:
Biopharmaceuticals, Oncology, FDA[IDM Pharma, Junovan, mifamurtide, Osteosarcoma]
ALTANA Pharma Receives Approval to Market Ciclesonide Nasal Spray in The U.S.
HSMN NewsFeed,
23 Oct 2006:
Biopharmaceuticals, FDA[ALTANA AG, OMNARIS , Ciclesonide, intranasal corticosteroid]
Bayer HealthCare and Regeneron to Collaborate on VEGF Trap for the Treatment of Eye Diseases
HSMN NewsFeed,
18 Oct 2006:
Biopharmaceuticals, Ophthalmology[Bayer HealthCare, Regeneron Pharmaceuticals, VEGF Trap, macular degeneration]
FDA Approves Allegra(R) (fexofenadine hydrochloride) Oral Suspension for Treatment of Seasonal Allergy Symptoms and Chronic Idiopathic Urticaria
HSMN NewsFeed,
18 Oct 2006:
Biopharmaceuticals, FDA[sanofi-aventis, Allegra, fexofenadine, Seasonal Allergy, Urticaria]
Taxotere(R) Receives U.S. FDA Approval for the Treatment of Patients With Head and Neck Cancer
HSMN NewsFeed,
18 Oct 2006:
Biopharmaceuticals, Oncology, FDA[sanofi-aventis, Taxotere, docetaxel, head and neck cancer]
Micromet, Inc. Expands Management and Appoints Christopher P. Schnittker as Senior Vice President and Chief Financial Officer
HSMN NewsFeed,
12 Oct 2006:
Biopharmaceuticals, Personnel[Micromet]
GlaxoSmithKline to Acquire CNS, Inc.
HSMN NewsFeed,
9 Oct 2006:
Biopharmaceuticals, Mergers & Acquisitions[GlaxoSmithKline, CNS Inc, Breathe Right, FiberChoice]
Cardax Pharmaceuticals Appoints Fred Pashkow, MD, as EVP/CMO
HSMN NewsFeed,
9 Oct 2006:
Biopharmaceuticals, Personnel[Cardax Pharmaceuticals]
Important safety information about KETEK (telithromycin)
HSMN NewsFeed,
4 Oct 2006:
Biopharmaceuticals[sanofi-aventis, KETEK, telithromycin]
Long-Term Data Demonstrated Significantly Better Patient Adherence to COPAXONE(R) versus Interferons in Multiple Sclerosis Treatment
HSMN NewsFeed,
3 Oct 2006:
Biopharmaceuticals, Neurology[Teva Neuroscience, multiple sclerosis, COPAXONE, glatiramer]
Amylin Pharmaceuticals Appoints Joe Young Sr. Vice President, Marketing
HSMN NewsFeed,
3 Oct 2006:
Biopharmaceuticals, Personnel[Amylin Pharmaceuticals]
Regeneron Names Peter Powchik, M.D., Senior Vice President of Clinical Development
HSMN NewsFeed,
3 Oct 2006:
Biopharmaceuticals, Personnel[Regeneron Pharmaceuticals]
FDA Grants Priority Review for ARIXTRA(R) (fondaparinux sodium) in the Treatment of Acute Coronary Syndromes
HSMN NewsFeed,
2 Oct 2006:
Biopharmaceuticals, Cardiology, FDA[GlaxoSmithKline, ARIXTRA, fondaparinux, acute coronary syndromes]
COPAXONE(R) Showed Sustained Benefit on Slowing Brain Tissue Damage in Multiple Sclerosis Patients
HSMN NewsFeed,
2 Oct 2006:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, COPAXONE, glatiramer, multiple sclerosis]
Very Active Multiple Sclerosis Patients Benefited from COPAXONE(R) Treatment Following Short-Term Induction with Mitoxantrone
HSMN NewsFeed,
29 Sep 2006:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, COPAXONE, glatiramer, multiple sclerosis]
Study Showed Significant and Sustained Efficacy Of COPAXONE(R) Alone Following Short-Term Combination Therapy With IV Steroids in Multiple Sclerosis Patients
HSMN NewsFeed,
29 Sep 2006:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, COPAXONE, glatiramer, multiple sclerosis]
Advancis Pharmaceutical Receives Judgment in Trademark Infringement Lawsuit
HSMN NewsFeed,
28 Sep 2006:
Biopharmaceuticals, Litigation[Advancis Pharmaceutical, sanofi-aventis]
New Data Confirmed Antibodies to COPAXONE(R) do not Impact Its Established and Sustained Long-Term Efficacy in Multiple Sclerosis
HSMN NewsFeed,
28 Sep 2006:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, COPAXONE, glatiramer, multiple sclerosis]
Avalon Pharmaceuticals Appoints David D. Muth to Executive Vice President, Chief Business Officer
HSMN NewsFeed,
27 Sep 2006:
Biopharmaceuticals, Personnel[Avalon Pharmaceuticals]
Millennium Agrees to Acquire AnorMED, Adding Phase III Oncology Product with Planned Near Term Launch Date
HSMN NewsFeed,
26 Sep 2006:
Biopharmaceuticals, Mergers & Acquisitions[Millennium Pharmaceuticals, AnorMED]
ProNAi Announces Executive Team Buildup, Names New CEO and Top Development Management
HSMN NewsFeed,
26 Sep 2006:
Biopharmaceuticals, Personnel[ProNAi Therapeutics]
sanofi-aventis and UCB Sign a Co-Promotion Agreement for Xyzal(R) in the United States
HSMN NewsFeed,
25 Sep 2006:
Biopharmaceuticals[sanofi-aventis, UCB, Xyzal, levocetirizine]
UCB and sanofi-aventis sign a co-promotion agreement for Xyzal(R) in the United States
HSMN NewsFeed,
25 Sep 2006:
Biopharmaceuticals[UCB, sanofi-aventis, Xyzal, levocetirizine]
Pharmion Corporation and GPC Biotech Announce Positive Results from the Satraplatin Pivotal Phase 3 Trial and Achievement of the Progression-Free Survival Endpoint
HSMN NewsFeed,
24 Sep 2006:
Biopharmaceuticals, Oncology[Pharmion, GPC Biotech, Spectrum Pharmaceuticals, satraplatin, prostate cancer]
Plavix(R) Preliminary Injunction Appeal
HSMN NewsFeed,
21 Sep 2006:
Biopharmaceuticals, Generics, Litigation[sanofi-aventis, Bristol-Myers Squibb, Apotex, PLAVIX, clopidogrel]
Kos Announces Positive Overall Results for Two Phase III Trials of Icatibant for the Treatment of Hereditary Angioedema
HSMN NewsFeed,
21 Sep 2006:
Biopharmaceuticals[Kos Pharmaceuticals, Jerini, Icatibant, FAST-1, FAST-2, hereditary angioedema]
Ranbaxy Receives Approval to Commercialize Furosemide Tablets in the U.S.
HSMN NewsFeed,
21 Sep 2006:
Biopharmaceuticals, Generics, FDA[Ranbaxy Pharmaceuticals, Furosemide, Lasix, Aventis]
EKR Therapeutics Expands Management Team
HSMN NewsFeed,
21 Sep 2006:
Biopharmaceuticals, Oncology, Personnel[EKR Therapeutics]
Dermik Laboratories Announces FDA Acceptance of Supplemental Filing Application for Sculptra(R)
HSMN NewsFeed,
19 Sep 2006:
Biopharmaceuticals, Dermatology, FDA[sanofi-aventis, Sculptra, poly-L-lactic acid]
UCB Appoints Fabrice Egros, Ph.D., MBA, President of U.S. Subsidiary
HSMN NewsFeed,
19 Sep 2006:
Biopharmaceuticals, Personnel[UCB]
ImClone Systems Issues Statement on Court Ruling in Litigation against Yeda
HSMN NewsFeed,
18 Sep 2006:
Biopharmaceuticals, Oncology, Licensing, Litigation[ImClone Systems, Yeda Research and Development, ERBITUX]
Avandia(R) (rosiglitazone maleate) Reduced Risk of Progression From Pre-Diabetes To Type 2 Diabetes by 62 Percent in Largest Completed Diabetes Prevention Trial
HSMN NewsFeed,
15 Sep 2006:
Biopharmaceuticals, Endocrinology[GlaxoSmithKline, Avandia, rosiglitazone, diabetes]
John Timberlake Joins Valeritas from sanofi-aventis as Executive Vice President and General Manager of Metabolics
HSMN NewsFeed,
12 Sep 2006:
Biopharmaceuticals, Personnel[Valeritas, BioValve Technologies]
European commission expands indication for PLAVIXŽ (clopidogrel bisulfate) offering new option for patients with most severe type of heart attack
HSMN NewsFeed,
7 Sep 2006:
Biopharmaceuticals, Cardiology, Regulatory[sanofi-aventis, PLAVIX, clopidogrel]
Catalyst Pharmaceutical Partners, Inc. Appoints Chief Medical Officer and Vice President of Regulatory Operations
HSMN NewsFeed,
7 Sep 2006:
Biopharmaceuticals, Personnel[Catalyst Pharmaceutical Partners]
The New England Journal of Medicine Publishes the STEEPLE Study Which Demonstrated Superior Safety Profile of LOVENOX(R)(Enoxaparin Sodium Injection) Vs. Unfractionated Heparin in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention (PCI)
HSMN NewsFeed,
7 Sep 2006:
Biopharmaceuticals, Interventional Cardiology[sanofi-aventis, STEEPLE trial, LOVENOX, Enoxaparin]
New Clinical Data Show Enoxaparin Significantly Reduced the Risk of Repeat Heart Attack and Stroke in Patients Undergoing Percutaneous Coronary Intervention (PCI)
HSMN NewsFeed,
5 Sep 2006:
Biopharmacetuicals, Cardiology[sanofi-aventis, PCI-ExTRACT-TIMI 25 study, Enoxaparin]
New Clinical Data Show Enoxaparin Significantly Reduces the Risk of Repeat Heart Attacks and Stroke in Patients Undergoing Percutaneous Coronary Intervention (PCI)
HSMN NewsFeed,
4 Sep 2006:
Biopharmaceuticals, Interventional Cardiology[sanofi-aventis, enoxaparin, percutaneous coronary intervention, coronary stent]
FDA Approves New Indication for PLAVIX(R) (clopidogrel bisulfate) Offering New Option for Patients With Most Severe Type of Heart Attack
HSMN NewsFeed,
17 Aug 2006:
Biopharmaceuticals, Cardiology, FDA[sanofi-aventis, Bristol-Myers Squibb, PLAVIX, clopidogrel]
SGX Pharmaceuticals Appoints Chief Medical Officer
HSMN NewsFeed,
15 Aug 2006:
Biopharmaceuticals, Personnel[SGX Pharmaceuticals]
IDM Pharma Appoints Sylvie Gregoire, Pharm. D., as Executive Chair of the Board of Directors
HSMN NewsFeed,
15 Aug 2006:
Biopharmaceuticals, Personnel[IDM Pharma]
Motion Filed for Preliminary Injunction in PLAVIX(R) Patent Infringement Case
HSMN NewsFeed,
14 Aug 2006:
Biopharmaceuticals, Litigation[Bristol-Myers Squibb, Sanofi-aventis, Apotex, clopidogrel, PLAVIX]
Amgen Wins TKT Appeal
HSMN NewsFeed,
3 Aug 2006:
Biopharmaceuticals, Litigation[Amgen, Transkaryotic Therapies, sanofi-aventis, erythropoietin]
PLAVIX(R) Litigation Settlement Fails to Receive Antitrust Clearance From States Attorneys General
HSMN NewsFeed,
28 Jul 2006:
Biopharmaceuticals, Cardiology, Litigation[Bristol-Myers Squibb, sanofi-aventis, Apotex, PLAVIX, clopidogrel]
Cerexa Appoints George H. Talbot, M.D., Chief Medical Officer, Executive Vice President
HSMN NewsFeed,
28 Jul 2006:
Biopharmaceuticals, Personnel[Cerexa]
Teva Initiates Phase III Study to Confirm Increased Efficacy of Higher Dose of Glatiramer Acetate for the Treatment of Relapsing-Remitting Multiple Sclerosis
HSMN NewsFeed,
27 Jul 2006:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, glatiramer, COPAXONE, Multiple Sclerosis]
New Data Support Long-Term Use of AMBIEN CRTM (zolpidem tartrate extended- release) Tablets C(IV) for up to 24 Weeks
HSMN NewsFeed,
12 Jul 2006:
Biopharmaceuticals[sanofi-aventis, AMBIEN CR, zolpidem]
ImmunoGen, Inc. Grants Biotest AG Rights to Use ImmunoGen TAP Technology to Develop Novel Anticancer Therapeutics
HSMN NewsFeed,
11 Jul 2006:
Biopharmaceuticals, Licensing[ImmunoGen, Biotest AG, Tumor-Activated Prodrug]
ARCA Discovery, Inc. Names Dr. Ann Lenich Hards Executive Vice President Regulatory Affairs
HSMN NewsFeed,
10 Jul 2006:
Biopharmaceuticals, Personnel[ARCA Discovery]
OXiGENE'S Board of Directors Names Experienced Biotech Executive, Richard Chin, M.D., as President and Chief Executive Officer
HSMN NewsFeed,
30 Jun 2006:
Biopharmaceuticals, Personnel[OXiGENE]
sanofi-aventis Announces Update to Ketek(R) (Telithromycin) U.S. Prescribing Information
HSMN NewsFeed,
29 Jun 2006:
Biopharmaceuticals, FDA[sanofi-aventis, Ketek, telithromycin]
Novo Nordisk Prevails in sanofi-aventis Challenge to Levemir(R) - Up to 24 Hours Duration of Action and Other Claims Upheld
HSMN NewsFeed,
27 Jun 2006:
Biopharmaceuticals, Litigation[Novo Nordisk, sanofi-aventis, Levemir]
BioAlliance Pharma Strengthens Operational Management Ahead of Loramyc(R) Launch
HSMN NewsFeed,
26 Jun 2006:
Biopharmaceuticals, Personnel[BioAlliance Pharma]
Positive Synvisc Data Presented at European Conference
HSMN NewsFeed,
23 Jun 2006:
Biopharmaceuticals[Genzyme, Synvisc, hylan G-F 20, Hyalgan, hyaluronate]
New Data Reveals That Enoxaparin Results in Significant Cost Savings Compared to Unfractionated Heparin (UFH) in Treatment of in-Hospital Patients at Risk for Venous Thromboembolism (VTE)
HSMN NewsFeed,
20 Jun 2006:
Biopharmaceuticals[Sanofi-aventis, enoxaparin, venous thromboembolism, VTE]
COPAXONE(R) Reduced Relapses By 75 Percent in Both Treatment-Naive Multiple Sclerosis Patients and Those Failing Betaseron(R)
HSMN NewsFeed,
20 Jun 2006:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, Teva Neuroscience, multiple sclerosis, COPAXONE]
International Trade Commission Acts on Novo Nordisk Complaint: Launches Investigation of sanofi-aventis
HSMN NewsFeed,
8 Jun 2006:
Devices, Biopharmaceuticals, Drug Delivery, Litigation[Novo Nordisk, sanofi-aventis, OptiClik]
Cubist Pharmaceuticals Names William Pullman as Senior Vice President and Chief Medical Officer
HSMN NewsFeed,
7 Jun 2006:
Biopharmaceuticals, Personnel[Cubist Pharmaceuticals]
FzioMed Announces Launch of UK Subsidiary & Appoints Amanda Cameron as UK General Manager
HSMN NewsFeed,
7 Jun 2006:
Devices, Personnel[FzioMed]
NPS Pharmaceuticals Appoints Francois Nader, MD, MBA, Chief Medical and Commercial Officer
HSMN NewsFeed,
6 Jun 2006:
Biopharmaceuticals, Personnel[NPS Pharmaceuticals]
Updated Analysis in Second-Line Treatment of Lung Cancer Trial Confirms Similar Survival for Alimta(R) and Docetaxel
HSMN NewsFeed,
4 Jun 2006:
Biopharmaceuticals, Oncology[Eli Lilly, ALIMTA , pemetrexed, non-small cell lung cancer]
Results of a Meta-Analysis Show Benefits of Taxotere(R) (Docetaxel) Regimens in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
HSMN NewsFeed,
3 Jun 2006:
Biopharmaceuticals, Oncology[sanofi-aventis, Taxotere, docetaxel]
COPAXONE(R) Reduced Relapses and Stabilized Disability as Measured by Expanded Disability Status Scale, When Avonex(R) Failed
HSMN NewsFeed,
31 May 2006:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, COPAXONE, glatiramer, multiple sclerosis]
Regeneron Receives Fast-Track Designation for the IL-1 Trap in CIAS1-Associated Periodic Syndromes (CAPS)
HSMN NewsFeed,
31 May 2006:
Biopharmaceuticals, FDA[Regeneron Pharmaceuticals, IL-1 Trap, Interleukin-1]
QLT strengthens corporate development and legal functions with the appointment of Peter J. O'Callaghan as Senior Vice President, Corporate Development and General Counsel
HSMN NewsFeed,
25 May 2006:
Biopharmaceuticals, Personnel[QLT]
Abraxis BioScience Bolsters Manufacturing and Global Operational Expertise With Key Senior Executives
HSMN NewsFeed,
25 May 2006:
Biopharmaceuticals, Personnel[Abraxis BioScience]
Oscient Pharmaceuticals Hires Philippe M. Maitre as Senior Vice President and Chief Financial Officer
HSMN NewsFeed,
22 May 2006:
Biopharmaceuticals, Personnel[Oscient Pharmaceuticals]
Astex Announces New Chief Executive Officer
HSMN NewsFeed,
10 May 2006:
Biopharmaceuticals, Personnel[Astex Therapeutics, Leon Bushara]
YM Biosciences completes acquisition of Eximias
HSMN NewsFeed,
9 May 2006:
Biopharmaceuticals, Oncology, Mergers & Acquisitions[YM BioSciences, Eximias Pharmaceutical]
Long-Term Copaxone(R) Study Showed 92% of Multiple Sclerosis Patients Were Still Walking Unaided After a Mean of 10 Years on Treatment
HSMN NewsFeed,
8 May 2006:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, COPAXONE, glatiramer, multiple sclerosis]
ImmunoGen, Inc. to Develop Commercial-Scale Manufacturing Process for Trastuzumab-DM1 for Genentech
HSMN NewsFeed,
4 May 2006:
Biopharmaceuticals[ImmunoGen, Genentech]
Perrigo Acknowledges Barr Patent Challenge of NASACORT(R) AQ Nasal Spray
HSMN NewsFeed,
4 May 2006:
Biopharmaceuticals, Generics, Litigation[Perrigo, Barr Pharmaceuticals, sanofi-aventis, NASACORT]
Coley Pharmaceutical Group Presents Data from Clinical Study of ACTILON(TM) for Hepatitis C at the European Association for the Study of the Liver Meeting
HSMN NewsFeed,
29 Apr 2006:
Biopharmaceuticals[Coley Pharmaceutical, Pegylated Interferon, Ribavirin, ACTILON, Hepatitis C]
Coley Pharmaceutical Group Appoints Ferdinand E. Massari, M.D., Senior Vice President, Drug Development
HSMN NewsFeed,
27 Apr 2006:
Biopharmaceuticals, Personnel[Coley Pharmaceutical]
Abraxis BioScience Announces Co-Promotion Agreement with AstraZeneca for ABRAXANE(R) in the U.S. and the Acquisition of AstraZeneca's U.S. Branded Anesthetic and Analgesic Product Lines
HSMN NewsFeed,
27 Apr 2006:
Biopharmaceuticals, Acquisitions[Abraxis BioScience, AstraZeneca, ABRAXANE]
NPS Names Juergen Lasowski, Ph.D., Senior Vice President of Corporate Development
HSMN NewsFeed,
24 Apr 2006:
Biopharmaceuticals, Personnel[NPS Pharmaceuticals]
Spectrum Pharmaceuticals Completes Acquisition of Oncology Drug Assets of Targent, Inc.
HSMN NewsFeed,
21 Apr 2006:
Biopharmaceuticals, Acquisitions[Spectrum Pharmaceuticals, Targent, Levofolinic acid]
Dr. Reddy's Receives USFDA Approval for Fexofenadine Hydrochloride
HSMN NewsFeed,
13 Apr 2006:
Biopharmaceuticals, Generics, FDA[Dr. Reddy's Laboratories, fexofenadine, sanofi-aventis, Allegra]
Mylan Announces Tentative Approval for Fexofenadine Hydrochloride Tablets
HSMN NewsFeed,
12 Apr 2006:
Biopharmaceuticals, Generics, FDA[Mylan Laboratories, Fexofenadine, sanofi-aventis, Allegra]
Valeant Pharmaceuticals' Chief Scientific Officer to Leave Company
HSMN NewsFeed,
11 Apr 2006:
Biopharmaceuticals, Personnel[Valeant Pharmaceuticals]
Appeals Court Rules in sanofi-aventis' Favor in the U.S. Lovenox(R) (enoxaparin sodium injection) Patent Infringement Case
HSMN NewsFeed,
10 Apr 2006:
Biopharmaceuticals, Litigation[sanofi-aventis, Teva Pharmaceutical, Lovenox, enoxaparin]
ARIXTRA(R) Significantly Reduced Major Bleeding Compared to LOVENOX(R) in a Study of Patients With Acute Coronary Syndromes
HSMN NewsFeed,
6 Apr 2006:
Biopharmaceuticals, Cardiology[GlaxoSmithKline, OASIS 5, acute coronary syndromes, ARIXTRA, fondaparinux]
QLT announces that Court of Appeals grants stay of injunction against Eligard(R) sales
HSMN NewsFeed,
5 Apr 2006:
Biopharmaceuticals, Litigation[QLT, Eligard]
Teva Announces That Higher Dose of Copaxone(R) Showed Increased Efficacy in Multiple Sclerosis (MS)
HSMN NewsFeed,
5 Apr 2006:
Biopharmaceuticals, Neurology[Teva Pharmaceutical, Copaxone, glatiramer, multiple sclerosis, RRMS]
QLT announces co-development and licensing agreement with Retinagenix for early stage ocular synthetic retinoid program
HSMN NewsFeed,
5 Apr 2006:
Biopharmaceuticals, Ophthalmology, Licensing[QLT, Retinagenix]
Artes Medical Names Diane Goostree President and Chief Operating Officer
HSMN NewsFeed,
3 Apr 2006:
Devices, Dermatology, Personnel[Artes Medical, ArteFill]
Merck Names Peter Loescher to Newly Created Position of President, Global Human Health
HSMN NewsFeed,
3 Apr 2006:
Biopharmaceuticals, Personnel[Merck]
TAXOTERE(R) Receives U.S. FDA Approval For Use In Advanced Stomach Cancer
HSMN NewsFeed,
23 Mar 2006:
Biopharmaceuticals, Oncology, FDA[sanofi-aventis, TAXOTERE, docetaxel, gastric cancer]
Apotex Announces Agreement to Settle U.S. PLAVIX(R) Litigation
HSMN NewsFeed,
22 Mar 2006:
Biopharmaceuticals, Generics, Litigation[Apotex, sanofi-aventis, Bristol-Myers Squibb, PLAVIX, clopidogrel]
Sanofi-aventis and Bristol-Myers Squibb Announce Agreement to Settle U.S. PLAVIX(R) Litigation with Apotex Subject to Certain Conditions
HSMN NewsFeed,
21 Mar 2006:
Biopharmaceuticals, Litigation[Bristol-Myers Squibb, sanofi-aventis, Apotex, clopidogrel, PLAVIX]
Coley Pharmaceutical Group Announces Top-line Data from a Clinical Study of Actilon(TM) for Hepatitis C
HSMN NewsFeed,
21 Mar 2006:
Biopharmaceuticals[Coley Pharmaceutical, Actilon, CPG 10101, Hepatitis C]
Abraxis Oncology Names Joseph Hogan Vice President of U.S. Sales and Marketing
HSMN NewsFeed,
20 Mar 2006:
Biopharmaceuticals, Oncology, Personnel[American Pharmaceutical Partners]
Statement Responding to Recent Media Reports Regarding Appropriate Use of AMBIEN(R) (zolpidem tartrate) CIV in the US
HSMN NewsFeed,
20 Mar 2006:
Biopharmaceuticals[sanofi-aventis, AMBIEN, zolpidem]
Spectrum Pharmaceuticals to Acquire NDA for an Oncology Drug and other Assets
HSMN NewsFeed,
20 Mar 2006:
Biopharmaceuticals, Oncology, Mergers & Acquisitions[Spectrum Pharmaceuticals, Targent, levofolinic acid]
MedImmune Broadens Management Team with Five Additional Leaders in Key Strategic Areas
HSMN NewsFeed,
15 Mar 2006:
Biopharmaceuticals, Personnel[MedImmune]
Brigham and Women's Cardiac Group Finds Enoxaparin Strategy is Better Than Commonly Administered Blood Thinning Strategy for Heart Attacks
HSMN NewsFeed,
14 Mar 2006:
Biopharmaceuticals, Cardiology[Sanofi-aventis, enoxaparin, ExTRACT-TIMI 25 trial]
IDM and Medison Pharma Sign an Exclusive Marketing Agreement for Junovan(TM) in Israel
HSMN NewsFeed,
14 Mar 2006:
Biopharmaceuticals, Distribution, Licensing[IDM Pharma, Medison Pharma, Junovan]
Vical Licensee sanofi-aventis Releases Phase 2b Angiogenesis Data and Plans for Phase 3
HSMN NewsFeed,
13 Mar 2006:
Biopharmaceuticals[ Vical , sanofi-aventis, Centelion, NV1FGF, Critical Limb Ischemia]
New Study Furthers Understanding of the Role of Dual Antiplatelet Therapy in the Prevention Of Atherothrombotic Events, Including Heart Attack, Stroke or Cardiovascular Death in Broad Population
HSMN NewsFeed,
12 Mar 2006:
Biopharmaceuticals, Cardiology[Bristol-Myers Squibb, sanofi-aventis, CHARISMA, Clopidogrel, Plavix, Iscover]
Robert S. Mills Elected Chief Executive Officer of Columbia Laboratories
HSMN NewsFeed,
7 Mar 2006:
Biopharmaceuticals, Personnel[Columbia Laboratories]
QLT Updates on the U.S. Eligard(R) Patent Litigation
HSMN NewsFeed,
6 Mar 2006:
Biopharmaceuticals, Litigation[QLT, Eligard, Sanofi-Synthelabo]
Nereus Pharmaceuticals Closes Second Tranche of $42.6 Million Financing
HSMN NewsFeed,
6 Mar 2006:
Biopharmaceuticals, Venture Capital[Nereus Pharmaceuticals]
Dynavax Presents Positive TOLAMBA Phase 2/3 Results at AAAAI Meeting
HSMN NewsFeed,
6 Mar 2006:
Biopharmaceuticals[Dynavax Technologies, TOLAMBA]
Pfizer Completes Acquisition of Worldwide Rights to Exubera From sanofi-aventis
HSMN NewsFeed,
1 Mar 2006:
Biopharmaceuticals, Endocrinology, Acquisitions[Pfizer, sanofi-aventis, Exubera , inhaled insulin]
Apidra(R) - a New Rapid-Acting Insulin Analog - Is Now Available in the United States for Hyperglycemia in Adults with Type 2 and Type 1 Diabetes
HSMN NewsFeed,
28 Feb 2006:
Biopharmaceuticals, Endocrinology[sanofi-aventis, Apidra , diabetes]
IDM Pharma Confirms Plans to Submit New Drug Application for Junovan(TM) for the Treatment of Osteosarcoma Following Pre-NDA Meeting with FDA
HSMN NewsFeed,
28 Feb 2006:
Biopharmaceuticals, Oncology[IDM Pharma, Junovan, osteosarcoma]
QLT intends to appeal U.S. Eligard injunction
HSMN NewsFeed,
27 Feb 2006:
Biopharmaceuticals, Litigation[QLT, sanofi-aventis, Sanofi-Synthelabo, Eligard]
King Pharmaceuticals Reports Agreement on Dismissal of Altace(R) Patent Litigation
HSMN NewsFeed,
27 Feb 2006:
Biopharmaceuticals, Generics, Litigation[King Pharmaceuticals, Sanofi-Aventis, Cobalt Pharmaceuticals, Altace, ramipril]
QLT's Board of Directors Appoints Robert Butchofsky as CEO
HSMN NewsFeed,
27 Feb 2006:
Biopharmaceuticals, Personnel[QLT]
Positive Findings from Clinical Studies of QUADRAMET(R) in Prostate Cancer Patients with Metastatic Bone Disease Presented at ASCO Prostate Cancer Symposium
HSMN NewsFeed,
27 Feb 2006:
Biopharmaceuticals, Oncology[Cytogen, QUADRAMET]
IDM and GENESIS Pharma Sign an Exclusive Marketing Agreement for Junovan(TM) in South East Europe
HSMN NewsFeed,
21 Feb 2006:
Biopharmaceuticals, Licensing[IDM Pharma, GENESIS Pharma, Junovan]
Genentech Submits Supplemental Biologics License Application for Adjuvant Herceptin(R) in Early-Stage HER2-Positive Breast Cancer
HSMN NewsFeed,
15 Feb 2006:
Biopharmaceuticals, Oncology, FDA[Genentech, Herceptin, Trastuzumab, breast cancer]
American Pharmaceutical Partners and American BioScience Announce Senior Management Team of Abraxis BioScience
HSMN NewsFeed,
14 Feb 2006:
Biopharmaceuticals, Personnel, Mergers & Acquisitions[American Pharmaceutical Partners, American BioScience, Abraxis BioScience]
QLT Announces Preliminary Findings From Phase II Clinical Trial Of Lemuteporfin-injectable In BPH
HSMN NewsFeed,
14 Feb 2006:
Biopharmaceuticals, Urology[QLT, lemuteporfin, benign prostatic hyperplasia]
Myogen Announces Sale of Myogen GmbH
HSMN NewsFeed,
2 Feb 2006:
Biopharmaceuticals, Mergers & Acquisitions, Licensing[Myogen, Myogen GmbH, Perfan , enoximone, Wulfing Holding GmbH]
Regeneron's VEGF Trap Demonstrates Positive Preliminary Results in Patients with Age-Related Macular Degeneration
HSMN NewsFeed,
2 Feb 2006:
Biopharmaceuticals, Ophthalmology[Regeneron Pharmaceuticals, VEGF Trap-Eye, macular degeneration]
Teva Announces Favorable Court Decision Regarding Generic Allegra
HSMN NewsFeed,
27 Jan 2006:
Biopharmaceuticals, Generics, Litigation[Teva Pharmaceutical, Aventis, Fexofenadine, Allegra]
Pfizer Receives FDA Approval for Exubera, the First Inhalable Form of Insulin for Controlling Type 1 and Type 2 Diabetes in Adults
HSMN NewsFeed,
27 Jan 2006:
Biopharmaceuticals, Endocrinology, FDA[Pfizer, Exubera , inhaled insulin, diabetes]
Barr Says Court Denies Preliminary Injunction to Halt Generic Allegra(R) Sales
HSMN NewsFeed,
27 Jan 2006:
Biopharmaceuticals, Generics, Litigation[Barr Pharmaceuticals, Aventis, Fexofenadine, Allegra]
European Commission Approves Exubera(R) (Inhaled Human Insulin) for Treatment of Type 1 and Type 2 Diabetes
HSMN NewsFeed,
26 Jan 2006:
Biopharmaceuticals, Regulatory[Pfizer, Exubera , inhaled insulin]
Peter Zundorf to Head up Schering's Oncology Business Area
HSMN NewsFeed,
26 Jan 2006:
Biopharmaceuticals, Personnel[Schering AG]
Millennium Announces Appointments of Executive Vice President of Commercial Operations, Vice President of Finance and Several Key Promotions
HSMN NewsFeed,
25 Jan 2006:
Biopharmaceuticals, Personnel[Millennium Pharmaceuticals]
Carlo Montagner to Be Named President of Abraxis Oncology Upon Completion of Merger of APP and ABI
HSMN NewsFeed,
25 Jan 2006:
Biopharmaceuticals, Personnel, Mergers & Acquisitions[American Pharmaceutical Partners, Abraxis Oncology]
ViroPharma Broadens Senior Management
HSMN NewsFeed,
19 Jan 2006:
Biopharmaceuticals, Personnel[ViroPharma]
FDA Grants Priority Review to PLAVIX(R) (Clopidogrel Bisulfate) Supplemental New Drug Application (sNDA) for Additional Type of Heart Attack
HSMN NewsFeed,
18 Jan 2006:
Biopharmaceuticals, Cardiology, FDA[sanofi-aventis, Bristol-Myers Squibb, PLAVIX, STEMI , clopidogrel]
Pharmix Announces Appointment of Jack M. Anthony as President and CEO
HSMN NewsFeed,
17 Jan 2006:
Biopharmaceuticals, Personnel[Pharmix]
MannKind Corporation Announces Positive Results From a Phase 2b Dose-Ranging Study of Technosphere(R) Insulin in Patients With Type 2 Diabetes
HSMN NewsFeed,
17 Jan 2006:
Biopharmaceuticals, Drug Delivery, Endocrinology[MannKind, Technosphere Insulin, inhaled insulin, diabetes]
Genta Appoints Seasoned Pharma Executive, Lloyd Sanders, as Vice-President for Sales and Marketing
HSMN NewsFeed,
17 Jan 2006:
Biopharmaceuticals, Oncology, Personnel[Genta Inc]
Pfizer to Purchase sanofi-aventis Rights to Exubera(R) in Application of Change of Control Clauses
HSMN NewsFeed,
13 Jan 2006:
Biopharmaceuticals, Acquisitions[sanofi-aventis, Pfizer, Exubera, inhaled insulin]
Pfizer to Acquire the sanofi-aventis Worldwide Rights to Exubera(R) (Inhaled Human Insulin)
HSMN NewsFeed,
12 Jan 2006:
Biopharmaceuticals, Acquisitions[Pfizer, Exubera, sanofi-aventis, Inhaled Insulin]
TESMILIFENE in Combination With TAXOTERE(R) (docetaxel) on Trial in Women With Rapidly Progressing Metastatic Breast Cancer
HSMN NewsFeed,
10 Jan 2006:
Biopharmaceuticals, Oncology[YM BioSciences, tesmilifene, TAXOTERE, docetaxel, breast cancer]
Columbia Laboratories Announces Management Changes
HSMN NewsFeed,
9 Jan 2006:
Biopharmaceuticals, Personnel[Columbia Laboratories]
Sapphire Therapeutics, Inc. Builds Drug Development Team Through New Hires and Promotion
HSMN NewsFeed,
6 Jan 2006:
Biopharmaceuticals, Personnel[Sapphire Therapeutics]
IDM Pharma Announces Departure of President
HSMN NewsFeed,
6 Jan 2006:
Biopharmaceuticals, Personnel[IDM Pharma]
ImClone Systems Names Cheryl Anderson Vice President, Regulatory Affairs
HSMN NewsFeed,
3 Jan 2006:
Biopharmaceuticals, Personnel[ImClone Systems]
Nastech Pharmaceutical Company Names Philip Ranker Chief Financial Officer
HSMN NewsFeed,
3 Jan 2006:
Biopharmaceuticals, Personnel[Nastech Pharmaceutical]
Additional items found: The Network Archive contains
500 additional itemsAventis
Public
Feeds 
Full text >>